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ABSTRACT
The process of sequencing a genome involves many steps, and accordingly, this
project contains work from each of those steps.

Genome sequencing begins with

acquisition of sequence data, therefore, a novel biochemistry was utilized and optimized
for the Sequencing By Ligation (SBL) process. A cyclic SBL protocol was created that
could be utilized to extend sequencing reads in both the 5’ and 3’ directions, for an increase
in read length and thru-put.
After sequence acquisition, there is the process of data analysis, and the focus
shifted to creating software that could take sequence information and match up the
individual reads to a reference genome with greater speed and efficiency than other
commonly-used software. The Sequence Analysis Workbench Tool, SAWTooth, was
written and shown to outperform contemporaries NOVOAlign and BOWTIE.
Finally, the last aspect of genome sequencing is de novo assembly, prompting a
comparative analysis of three assemblers: CLC Genomics Workbench, Velvet Assembler,
and MIRA. Results were generated using Mauve to assess the general effects of different
sequencing platforms on the final assembly.
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Chapter 1
Introduction
Next-generation sequencing is broad in both its potential applications as well as the
component parts, requiring a wide expanse of expertise and background to accomplish.
Genome sequencing is a versatile tool, and its most fundamental use is to simply gain the
sequence information of genes and genome, though even such a simple endeavor is still a
complicated affair to achieve. The completion of the Human Genome Project did not signal
the end or the apex of sequencing technology, but only its beginnings. Though it was a
monumental achievement, it was not sufficient to categorize and pinpoint molecular
pathways of disease (1,2). Certain diseases were easy enough, monogenic diseases such
as cystic fibrosis, those determined by single alleles, and work to track those genes were
already underway without using sequencing technology (3-5). Sequencing technology in
these cases could give a very clear diagnosis by seeking and sequencing the allele in
question. However, sequencing technology is ideal for the categorization and diagnosis of
complicated, multi-genic diseases, and the identification of genetic markers for
predisposition to diseases states (6-12).
One application of next-generation sequencing is to sequence cancer genomes with
the intention to identify oncogenes, whether they were inherited genes that increased cancer
susceptibility or somatic mutations that led to the development of tumor tissue. Cancer
presents a different and interesting problem than other polygenic diseases, though they
share many overlaps from the angle of genetic analysis. Polygenic diseases can include
heart disease or Alzheimer’s, and along with cancer, have potentially inherited genetic

1

traits that can affect predisposition to these disease states (3-5,13). BRCA1 and BRCA2
were both discovered to be inherited traits that increased breast cancer rates, whereas
mutations in p53 or the Rb gene seemed to increase general cancer susceptibility. These
inherited traits could be detected by sequencing germline genomes from individuals (1416). Cancer provides the interesting case of somatic mutations which are as determinative
in risk and susceptibility. This results in the need, in addition to having a reference human
genome, to sequence multiple genomes from a single patient in order to provide a more
complete assessment of disease risk (7,14,17-19). This complication is layered on top of
the more usual genetic aspects of interest: mutated genes, specific SNPs, translocations, or
copy number variations (19,20). All of these can have varying effects on disease states,
which is further convoluted by environmental impacts and penetrance of the observed
genetic abnormalities. This leads to constant demand for greater sequencing standards in
sequencing speeds, fidelity, and read lengths (21-25).
In the acquisition of sequencing information, various biochemistries and
methodologies are employed, that all have aspects that can be improved and further
optimized (26-28). The sequencing medium can vary, utilizing beads that are either iron
and therefore magnetic, or comprised of polystyrene, making them non-magnetic (29,30).
These methods can be performed in real-time or in cycles (31,32). The genetic template
can be amplified or not, relying on single-molecule sequencing (2,33,34). Detection
methods can involve fluorophore-coupled oligomers, or the detection of liberated hydrogen
ions during synthesis, or luciferase (32,35). Sequencing can involve different enzymes,
such as ligases for Sequencing By Ligation (SBL), polymerases for Sequencing By
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Synthesis (SBS), or can involve no enzymes, such as in Sequencing By Hybridization
(SBH) (26,27,29,36).
SBL in particular, has a limitation in read-lengths, though it can provide bidirectional reads (30) unlike traditional SBL approaches. One project of this dissertation
focused on increasing the read lengths of traditional SBL by utilizing a non-proprietary
method that involved using deoxyinosine as both a universal base and a substrate to be
recognized by Endonuclease V (37). This method could be performed with off-the-shelf
reagents and increased read-lengths through cyclic digestion and re-ligation. Results
increased traditional SBL results from approximately seven bases or so to thirteen
contiguous bases in the 3’ to 5’ direction. Using mate-paired tags with this cyclic SBL
variation would enable > 95% coverage of the genome. The potential gains of this cyclic
SBL variation were calculated using in-house developed software, the Sequence Analysis
Workbench Tool (SAWTooth) (38).
Once the sequence information has been generated and gathered, many steps of
analysis must be performed, depending on the desired information. In the case of cancer
genome sequencing, variations in the genome would yield the most interest; whether
differences between patient germline and reference genomes for hereditary factors, or
between germline and tumor tissue for somatic variations (14-16,39,40). One of the first
steps is simply matching these tags to the reference genome, filtering out those that match
perfectly and identifying SNPs and Indels (41-43). SAWTooth’s capability in this regard,
and ability to simulate potential gains from the cyclic SBL variation is not unique (44-47),
however, SAWTooth was able to perform this task far more efficiently than other existing
codes. This is important because the sizes of datasets being generated to adequately
3

sequence the human genome, which is three gigabases long, have become extremely large,
and an efficient algorithm to perform this mapping was necessary (46,48). SAWTooth
uses a pre-compiled hash-indexing algorithm to achieve faster mapping times, and even
with the time required to compile and generate the hash indexes, still demonstrated faster
match times for short mate-paired tags.
The last component of the dissertation is meta-analytical in nature, comparing a
selection of de novo assemblers and assessing their ability to assemble a known genome
given real and simulated mate-paired and single tag data. There is currently a large
selection of de novo assemblers to choose from. Many assemblers support reference
mapping as well, since it is a less complex computational task (25,49,50). There are
commercial, free, and open-source assemblers and they each utilize different algorithms.
Many of them have been used in the publication of draft genomes, though predicting
accuracy of a draft genome that has been assembled de novo is difficult (41,49,51). There
is no real verification, and often re-sequencing efforts reveal errors with rearrangements
and translocations in the assembly. Therefore, it seemed prudent to analyze a few of the
most used and popular assemblers in widespread use today.
All these topics are separated by both subject and field, but are all necessary to
collectively form the steps of next-generation sequencing. Each of these steps is obviously
complex, and this dissertation only explores one small facet of each, whether dealing with
sequencing biochemistry, cancer biology, reference mapping or de novo assembly.
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I. Introduction
The Human Genome Project (HGP) was one the greatest achievements of the 20th
Century, and the publication of the full human genome sequence in 2001 ushered in the
new century by starting the post-genome era in human biology. The great success of the
HGP has paved the way to many future discoveries. The human genome sequence
represents just the beginning of the payoffs for the biomedical community, and many future
benefits are promised and expected in the near future. Specifically, the HGP has enabled
the rapid sequencing of more genomes, such as cancer genomes, and this holds the potential
to transform cancer research and treatment. Therefore, it is more appropriate to look at the
completion of the human genome as the end-of-the-beginning, rather than the beginningof-the-end of the era of human genome sequencing.

“Next generation” sequencing

technologies are providing fast, cheap and high quality sequence. As these technologies
become less expensive and easier to operate, they will become more widely available.
However, the bottleneck in the process will quickly shift to the analysis phases. In other
words, making sense of the vast amount of sequence data will be a challenging task, and it
will require bioinformatics and systems biology. The analysis of sequencing data will
likely have a tremendous impact on many areas of medicine and biomedical research.
The sequencing and publication of the human genome was performed
simultaneously by two competing groups, one was publicly funded and the other was
privately funded. The publicly funded sequencing project was led by Dr. Francis Collins
and was performed in the classical clone-by-clone approach using traditional Sanger
sequencing. The private sequencing project was based at Celera and was led by Dr. J.
Craig Venter. The Celera group sequenced the human genome using the shotgun
10

sequencing approach, which was made possible for three main reasons: (a) they developed
novel assembly algorithms, (b) they utilized data from the public project, and (c) they
sequenced a very homogeneous sample, as opposed to a sample representative of a large
number of individuals. (1)
The HGP’s impact on future human genome sequencing has two broad
implications. First, the HGP has now established a reference human genome sequence,
allowing for relatively rapid sequencing of future genomes while using the reference
sequence to align reads. Additionally, a major impact of the HGP has been spin-off
technologies and bioinformatics tools, which have led to what is now known as “nextgeneration” sequencing technology. (2)
II. Next Generation Sequencing Technologies
During the HGP, a number of technologies were developed with the goal of
increasing sequencing throughput to allow for cheap and rapid human genome sequencing.
The first phases of the improvements were essentially advances in instrumentation and
miniaturization of the traditional Sanger sequencing approach. However, a number of true
next generation technologies were also developed and have become widely available.

Sequencing Template Preparation

11

The first step of the next generation sequencing pipeline is the construction of the
sequencing library. The library preparation step essentially takes a genomic DNA sample,
and converts it into DNA molecules that can be sequenced by a given sequencing
technology (see Figure 1). For example, sequencing using the Illumina system, fragments
the genomic DNA into ~300 bp fragments, amplifies these fragments via PCR and ligates
sequencing primer sites to the ends of the fragments.(3-5) These protocols vary in
complexity depending on the sequencing platform.
Additionally, genome libraries can be constructed to contain mate-pair sequences.
This means that the genome tags will be adjacent in the library molecule, but will have a
kilobase or more separation in the genome. The mate-pair approach complicates library
preparation, but assists in genome assembly/mapping, especially when dealing with very
12

short read lengths, as is typical in most next generation sequencing technologies (see Figure
2). (3-5)

There are many ways to sequence DNA, and because of this, there are many ways
in which to prepare the DNA libraries for sequencing. First, the template can be clonally
amplified unless sequencing can be performed on single molecules without the need for
amplification. Methods that do not rely on an amplification step are known as singlemolecule sequencing methods.

Amplification is necessary for many sequencing

approaches because a signal, whether it is light or electrical, must be amplified or would
be too weak to identify otherwise. This amplification can occur through an emulsion PCR
(ePCR)(6) step or through solid phase PCR as in the Illumina Inc. system. Additionally,
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rolling circle amplification (RCA) can be utilized to amplify the DNA into a ball, which
may itself be coupled to an array (see Figure 1). (7) Clonal amplification may make certain
sequencing approaches possible, however, when clonal amplicons are being sequenced, the
issue of phasing arises. For example, when a clonal population of DNA molecules is being
sequenced, the initial signals for sequencing each base are near identical for all molecules.
However, as sequencing progresses, inefficiencies in biochemistry, enzymatic activity,
chemical cleavage steps, or incomplete washing causes the signal to become noisy and may
contain an earlier (lag phasing) or later (lead phasing) position.
Single-molecule sequencing template preparation is greatly simplified, as there is
no need for amplification, and there are no amplification biases that may occur. Some
single-molecule sequencing methods also make real-time sequencing possible, though
there are obstacles to single-molecule sequencing that methods must take into account,
such as being able to recognize the signal of a single molecule, which requires more
expensive and larger sequencing equipment. (8)
Sequencing By Synthesis

Fluorescent Methods
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The most popular next generation sequencing approach is known as SequencingBy-Synthesis (SBS). In SBS, a DNA polymerase is used to extend a primer on the template
strand (see Figure 3). (3-5) The DNA template to be sequenced must contain a known
region at its 3’ end to hybridize a primer. Once hybridized, synthesis is allowed to occur
under controlled conditions with specific reagents.

The goal is to allow only the

incorporation of a single nucleotide onto this growing strand and to visualize the base that
was incorporated. The key is to modify (block) the nucleotides in some fashion that not
only allows termination of synthesis once incorporated, but also can be reversible. These
can, for example, involve a blocking group on the 3’ OH of the growing DNA strand that
can be removed enzymatically or by a chemical cleavage reaction.(3-5) The second
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element is to attach unique fluorophores onto each of the four different nucleotides to allow
visualization. After imaging, and storing this data, the termination must be reversed by
removing this blocking group, to allow the addition of another single nucleotide, and then
the fluorophores must be cleaved to visualize the signal of the newly incorporated
nucleotide. This process is repeated to sequencing up to ~150 bases. SBS can be performed
on clonal amplicons from an amplification step (i.e. sequencing being carried out on beads
or a clonal cluster of DNA), or SBS can be performed on a single molecule. (3-5,7)
SBS can also be performed in real-time with single-molecule visualization. Realtime SBS methods are faster, but constrained to the viewing area limitations of a camera
mounted microscope. Real-time sequencing approaches will likely have a significant
impact on cancer systems biology. This is because real-time sequencing has the potential
for very long reads, requires a very simple library preparation, and can readout epigenetic
markers, such as methylation and hydroxymethylation (9).
Non-fluorescent Methods
In addition to using fluorophores to identify incorporated bases, there are other
methods to measure and quantify DNA polymerase extension, such as detecting the H+ or
pyrophosphate released during polymerase extension. Since all bases give the same
pyrophosphate or H+ signal this sequencing approach requires cycles of extending with
each of the individual nucleotides. This sequencing approach has the advantage of using
natural nucleotides; however, this introduces the homopolymer repeat problem. Namely,
these types of sequencing methods must record the intensity of such a signal to deduce how
many bases of the same type were incorporated in homopolymer repeats.

16

While

distinguishing the difference in signal between single or double nucleotide incorporation
events is straight-forward, it is harder to discern the difference between five or six
incorporated nucleotides in a homopolymer repeat. (3-5)
The measured signal can be pH changes, as induced by the release of hydrogen
atoms when incorporating a nucleotide during synthesis, or there can be other enzymes
involved such as luciferase and sulphurylase that create a flash of light when a phosphate
is released during the same process. Due to the nature of this method, sequencing is
performed in real-time, and tends to have lower throughput than fluorescent, sequential
array methods.
Sequencing By Ligation
Sequencing By Ligation (SBL) uses a ligase and a series of query primers to
sequence a template strand. The template DNA to be sequenced will contain the unknown
genomic tag, flanked by a known region. The main disadvantage of this sequencing
approach is that the read lengths are very short. Therefore, to obtain a reasonable read
length, a complicated library preparation is required. The sequencing strategy is to
hybridize an anchor primer onto a known region, and ligate a query primer to the anchor
primer to sequence the unknown genomic tag. Ligation is determined by hybridization of
that query primer next to the anchor primer, meaning it must be complementary for the
unknown tag region. The query primers are degenerate, a mix that contains all possible
combinations for every position except for one. For example, when determining the
identity of the first base next to the anchor primer, the query primer set will be degenerate
for all positions, however, in this set, all query primers that have an adenine in that first
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position will have a specific fluorophore attached to the other end of the query primer (see
Figure 4). (3-5) The clonal features (i.e. beads) will then be imaged, in a manner similarly
to fluorescent SBS, and each specific fluorescent signal corresponds with specific bases.
This is repeated to obtain the identity of the second base, however, now the fluorophores
are specifically linked to bases in the second position of that query primer. This is repeated,
generally to a length of 7 nucleotides.

The reason for this read-length limitation is that base pairing is specific closer to
the site of ligation and less so further out. To get longer reads, cleavage of the ligated
query primer is performed, resulting in loss of the fluorophore and effectively, extending
the anchor primer into unknown regions of the genomic tag (see Figure 4). For example,
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after sequencing the 2nd base of a tag, and imaging the array, the signal and query primer
can be cleaved after the 5th base. The anchor primer will be extended five bases. Now
when using same query primer that sequenced the 2nd base, it will now sequence the 7th
base. Repeat the process, extend the anchor primer by another five bases, and sequence
the 12th base with the same query primer. This is repeated to get longer reads. When signal
becomes too weak to continue, the growing ligated template is removed and the sequencing
can be repeated to sequence further, for instance, the 3rd, 8th, 13th … positions. This is
repeated overall to obtain a contiguous sequence for the genomic tag.
The read-lengths of SBL are shorter than those obtainable from SBS, however, SBL
can be performed in both 5’ to 3’ as well as 3’ to 5’ directions, whereas SBS must be
performed in the direction of DNA synthesis. Similarly to SBS, SBL can be performed on
DNA amplified on beads or DNA clusters, and many different types of enzymes or
chemicals can be used to cleave the query primer. SBL can suffer from phasing errors as
well through repeated ligation and cleavage, but the problem is reduced through changing
anchor primers, the entire array is “reset” by washing with a buffer that strips and singlestrands the DNA.
Sequencing Through DNA Observation
In addition to methods that involve sequencing a template strand by building a
complementary sequencing strand through SBS or SBL, there are emerging methods of
sequencing that focus on observing certain traits of the DNA itself. These methods are
always single-molecule sequencing methods, and as of this writing, are not commercially
available. (10)

19

A key to observing DNA is to make the DNA single-stranded and pulling this
single-stranded DNA through a detector or a nanopore. As the DNA passes through the
nanopore, a detector must measure the electrical current which is different for each of the
individual nucleotides as they pass through the nanopore. (11)
In addition there is also a method to sequence DNA by directly visualizing it using
electron microscopy. This involves stretching the DNA on a surface and visualizing the
DNA by conjugating metal ions to specific nucleotides, which are read out in the respective
order using electron microscopy. (12)
III. Analysis of Sequencing Information
Sequencing the genome was a monumental task in of itself, but deciphering the data
is critical and complicated. The human genome is three billion base pairs long, and humans
are diploid, and thus each individual carries two homologous chromosomes. Furthermore
the genome is not simply a random arrangement of the four bases. If it were random,
sequencing it would be a lot easier. However, when Mother Nature finds a motif or a
protein shape that functions well, she will use it again and again. While this conservation
of form and function is elegant and pragmatic, it makes sequencing difficult. These motifs,
and regions of similarities may span hundreds of bases and may be located far apart. There
are also regions of extreme redundancy called microsatellites, where short patterns, one to
six bases in length, will repeat over and over again. These traits make the genome difficult
to sequence, but there are sequencing methods to mitigate these obstacles. (13)
Various sequencing technologies have varying read lengths and the longer the read
length, the easier it is to sequence redundant regions of the genome since many sequencing
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reads will contain part of the redundant region as well as more uniquely identifying
adjacent regions. Long read length assists greatly in allowing one to align, or put together,
the sequences obtained from a sequencing run. Another important trait to consider is how
many reads one can obtain from the genome The number of reads multiplied by the average
read length gives the total number of bases sequenced, and this product divided by the
genome’s size (three billion for humans) gives us the coverage. Coverage is important for
identifying Single Nucleotide Variations (SNVs), since an altered base pair will not align
to a reference genome, it is necessary to re-sequence that difference to gain confidence.
(13) It is estimated that to identify a large percentage of SNVs would require a coverage
of 30x, or at least 100 gigabases of sequence. Lastly, the raw accuracy of the sequencing
method must be taken into account. Most current next generation sequencing methods can
generate sequence with 98-99% raw accuracy.
These factors impact the ability to assemble the sequencing information into a
genome. It takes much more information with longer reads to assemble a genome without
a reference, or de novo sequencing. When a reference sequence is available, shorter reads
can be tolerated, since these reads can be aligned to a completed reference genome. This
is the most common method for human genome sequencing today, however, information
is lost with this approach, namely, information regarding structural variation cannot be
resolved from these sequencing studies. Additionally, phasing the SNVs are also not
determined, in other words, which of the two homologous chromosomes contain which
variant cannot be determined.
The goal of genome sequencing is to ultimately use this information and improve
medical treatment for various disease states that are influenced by genetic factors, such as
21

heart disease and of course, cancer. (14,15) The strategy is to catalogue genetic differences
that had led to the development of cancer, as well as use this information to engineer
specifically targeted therapeutic measures. The sequence information and what can be
inferred varies on the nature of the information, how the sequence was obtained, and what
it was compared to.
The practice of associating disease states with specific genome information is
Genome-Wide Association Studies (GWAS).

GWAS were initially performed with

microarrays that targeted specific candidate genes and known SNPs across the genome.
However, in cancer the problem is much more difficult. Namely, it is unlikely that a single
SNV that may be the direct cause of a disease, such as a single base difference in a chloride
ion channel that leads to Cystic Fibrosis. There are a myriad of genes that contribute and
protect against tumor progression, all of which interact in a manifold of ways. GWAS
therefore require significant sample sizes, and detailed genomic information to determine
the nature of the SNVs as they pertain to cancer. Each SNV confers a small percentage of
increased or decreased protection to cancer, whether they act in DNA repair pathways, cell
growth, or metastasis. However, as genome sequencing technology has advanced, it’s not
simply a matter of categorizing SNVs in patient samples and determining novel cancer
genes, but also genome rearrangements or copy number arrangements. (16,17)
Single Nucleotide Variations
Complete genome sequencing can reveal information about SNVs, which in turn,
can provide information about the resulting protein after translation if the SNV resides in
an exon. Even if a SNV is not located within an exon, changes to promoter regions for
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example, may impact the transcription of a gene and the subsequent amount of protein
product which may then affect cancer development. (18)
These SNVs can be substitutions from one base pair to another, which may result
in the usual gamut of synonymous, non-synonymous, or non-sense mutations, which may
or may not change the amino acid and the protein produced. In addition, there could be
insertions or deletions (sometimes collectively referred to as indels), which can also result
in a frame-shift that completely alters the protein product made.
Cancer sequencing requires a high coverage to accurately detect SNVs. Therefore,
high coverage, or repeatedly sequencing the same SNV containing region many times will
allow the SNV to be called with confidence. Without high coverage, the sequence
information may simply be thrown out, incorrectly labeled an inaccuracy in the sequence
acquisition itself.
Structural Variations
Chromosomal rearrangements may be caused by a number of factors, and there is
a range in consequences for these events. Even between healthy individuals, genome
structure will vary without observable detrimental effects. However, it is also clear that
rearrangements can have effects on disease states. (19-21)
To obtain information about rearrangements, translocations, insertions, and
deletions genome sequence over a wide range must be obtained, even if that entire range
isn’t sequenced directly. In other words, mate-pair sequencing is crucial for discerning
structural variations. In mate-pair sequencing, two short reads are obtained, but in addition
to the sequence, the relative position of these two reads is known. This knowledge of how
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these two reads are connected is critical for uncovering structural variation. For example,
if one cannot map the two short reads to an area in the reference genome, but find that the
mate-pairs map too close or too far, it is possible to make inferences about whether a large
indel is involved or if that region was rearranged completely. The key is having a library
that is constructed with the mate pair design, as well as having an adequate coverage to
increase the confidence of found structural changes.
Copy Number Variations (CNVs) are another type of structural variation which is
similar to indels, involving either the deletion or duplication of large parts of the genome,
which results in increased or decreased, or even deleted copies of genes. (22,23) CNVs
can effectively result in the under expression of key tumor suppressors or over expression
of oncogenes, resulting in cancer development. CNVs are obtainable from genome
sequencing, although there are optimized protocols to specifically identify these.
Identification of CNVs with genome sequencing can be difficult, and special attention
during the sequencing and library preparation must be made if this information is desired.
Somatic Mutations and Inheritance
A cancer genome will contain more sequence variants than a “normal” germline
genome. Specifically, in addition to the natural SNPs in the individual, the tumor will also
contain a number of somatic mutations and structural changes. (24-26) Therefore,
sequencing a genome that comes from a cancer patient’s tumor will identify many more
alterations in the genome than sequencing a genome from non-tumor tissue. It is assumed
that an individual develops cancer due to mutations occurring in cells that results in those
cells being positively selected for in terms of growth. There are many key areas in cell
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growth and regulation that need to be perturbed to allow tumor development; DNA repair
pathways, cell growth and division, apoptosis, etc. Therefore, the differences between the
tumor genome and the germline genome are considered somatic mutations. These somatic
mutations are considered important because a subset of these mutations gave rise to
tumorigenesis.
This gives researchers options when comparing cancer genomes in order to obtain
the information they consider relevant. Comparison of a patient’s germline genome with
reference genomes will assist in finding inherited genes that may have contributed or
increased a patient’s risk for cancer. On the other hand, comparison of a patient’s germline
and tumor genome will reveal a list of somatic mutations that may have lead to the
development of cancer. There is a risk however, in identifying somatic mutations because
one of the hallmarks of cancer development is lax DNA repair and reduced apoptosis.
Therefore, a cancer genome will have many mutations that have nothing to do with cancer
development because pathways that would normally stop further mutations have already
been damaged.
Drivers and Passengers
The difference between a mutation that leads to cancer development and those
mutations that are merely the result of a cancerous cell allowing other mutations to
randomly arise are the difference between so-called driver and passenger mutations.
Drivers are present due to selection during cancer development, whereas passengers have
been mutated and have no functional consequence. (27,28) Consequently, on top of
analyzing data and statistically determining what mutations are even real, one must
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determine what mutations are important. Experimental verification of a potential driver
mutation would be time consuming, requiring careful bench science experiments with
observations of knockouts and knockdowns of the candidate genes. Depending on the
organism used, results may or may not even be relevant. Experimental verification would
also run counter to how data from genome sequencing is generated, which is a discoverybased approach to research. There are other potential methods reliant upon pre-existing
knowledge about genes and their function, where mutation driver or passenger status can
be verified with a literature search. However, this still falls in the same trap of requiring
time-consuming experimental verification.
To discover and classify driver and passenger mutations and genes through genome
sequencing alone would require a much larger sample size. Only through a large database
of high-quality genome sequences will true driver mutations be made evident. Different
cancer types most likely have different somatic evolution, creating a need for a large
sample size of human genomes, but also for patient genome information for each specific
cancer. (27,28)
There are computational approaches that have been developed to look at the
complete set of somatic mutations and identify putative cancer genes, or basically separate
out the driver and passenger mutations (see Figure 5). To identify somatic mutations,
complete genome sequencing on a patient’s germline and tumor tissue must be carried out.
Comparisons between the two will yield a list of differences that must be processed
thoroughly. SNVs that, for example are in introns or are synonymous, are eliminated and
classified as passenger somatic mutations. Once driver and passenger mutations are
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identified, a validation must ultimately be performed to confirm whether these somatic
mutations had an effect on cancer development.

IV. Cancer Genome Sequencing Strategies
SNP Profiling
Single Nucleotide Polymorphism (SNP) profiling is not actually sequencing,
however, it is a useful, and relatively low cost, genotyping tool for analyzing a large sample
size. (29-32) In fact, it is the ability to perform a study with a large sample size that is SNP
profiling’s greatest strength. SNP profiling is performed with SNP arrays, which have been
following similar trajectories as next-generation sequencing in terms of throughput,
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increased number of SNPs investigated per array, etc. The SNPs on the array may not have
anything to do with cancer, but with large sample sizes, regions of the genome can be
identified and these regions can be studied in great detail using targeted resequencing
strategies on a very large sample size (a sample size much too large for full genome
sequencing). In addition, SNP profiling can provide CNV information that will also be very
useful in tracking down cancer causing genes.
Paired-End Mapping
Paired-End mapping is a type of genome sequencing strategy that can more
effectively provide information about genome structure and variation (33,34). Variations
in structure can cause varying expression in cancer developmental pathways by altering
expression. Similar to SNPs, even healthy individuals will differ greatly in terms of
genome structure, (35) but there are obviously variations that can lead to an increased risk
of cancer. Genomic structural changes may also impact other factors, such as by disrupting
exon and intron organization, leading to altered proteins. Additionally, CNV may be
affected as well as gene synteny or order.
Paired-end mapping can be performed on many different sequencing methods,
whether it is various SBS or SBL methods. Paired-End mapping requires a library that has
been mate-paired, where two reads are separated by a known distance. For the specific
applications of pair-end mapping, a larger separation distance is often required, due to the
fact that indels may be several kilobases in length. Genome structural variations may be
investigated with arrays, but next generation sequencing methods allow higher resolution
mapping.
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Targeted Resequencing
The human genome is very large, and researchers may be more interested in
obtaining more focused information, such as focusing purely on the exome (all exons), (3638) or even epigenetic changes such as the methylome (all methylated genes) (39,40) or
the kinome (all kinased genes). (38,41) For example, the exome, in addition to being about
2% of the entire genome, is focused on only the expressed regions of the genome where
many (if not most) of the important somatic driver mutations will lie. Additionally,
targeted resequencing could focus on the transcriptome, where sequencing the
transcriptome provides information about variation in the expressed exons as well as
important information regarding the gene expression level and splice variants. Splice
variants as well as expression information on these variants can provide valuable insight
into how genomic sequences translate into protein products.
Exome sequencing is the targeted sequencing of all known exons.

Exome

sequencing has advantages and disadvantages with respect to transcriptome sequencing.
First, the advantages of exon sequencing are that all exons are equally represented so the
coverage is essentially equal, minus stochastic effects, across all exons, whereas in
transcriptome sequencing the highly expressed exons are present in large excess and hence,
over sampled and the lowly expressed exons are often not adequately covered. Also,
information is gathered about all exons, not only the expressed exons as in transcriptome
sequencing. As in transcriptome sequencing, findings are consolidated into areas of the
genome that are translated. (42,43) The disadvantage to exon sequencing is the complexity
associated with isolating all exons from the genome, however, there are currently “kits”
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available to enrich for all exons and these approaches are becoming easier and cheaper.
The most common methods for exon enrichment are PCR and capture-based approaches.
The first complete exon sequencing study was undertaken by Sjoblom et al (44) in
a study focused on colorectal and breast cancer. A total of eleven colorectal cancer
samples, along with eleven breast cancer samples, and their corresponding normal tissues
were sequenced. The entire exome was sequenced with over thirteen-thousand genes. The
identified variations were narrowed down to identify cancer related mutations by
eliminating synonymous mutations, as well as SNVs that were present in the germline
normal. This approach has the added benefit of consolidating their findings into exons,
which focuses the found changes into actual translated sequence.
Whole Genome Sequencing
Whole genome sequencing is self-explanatory, sequencing is performed on the
entire genome in its entirety with its introns, exons, non-coding regions, repetitive regions,
telomeric regions, etc. (45-48) Everything is obtained and in effect, will provide all the
information that the above methods can give and more, with the exception of expression
based data. In addition to SNVs, no matter whether they reside in introns, exons, and
uniquely, non-coding regions will be discovered, as well as structural changes and copy
number variations. These differences can all be discovered using just whole genome
sequencing, as opposed to performing different sequencing methods to get various
information. (3,13) Additionally, chromosomal rearrangements are detectable through
whole genome sequencing, as opposed to other methods, which seek to parse down the
information. The drawback of whole genome sequencing is the massive and redundant
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human genome, making whole genome sequencing expensive and laborious. This often
results in greatly reduced sample sizes, making statistically significant observations
difficult. Not only is the acquisition of sequence data more stringent in its requirement,
but the alignment and assembly of information, even with the aide of a reference, is still
problematic.

This significant obstacle must be tackled from a computation angle.

Regardless, the high quality information of whole genome sequencing is the most detailed,
and therefore has the most potential to be useful.
The first full cancer genome sequencing study was performed by Ley et al. (49)
They used the Illumina sequencing platform, which is SBS based. They were able to
identify a complete set of somatic mutations that resulted during tumor progression, and
were able to identify ten potential cancer genes with acquired mutations, only two of which
were previously described.

Large parsing of the data was necessary to find the cancer

genes, as the original analysis found 2,647,695 single nucleotide variations (SNVs) after
quality control checks. 2,584,418 were also found in the patients’ germline which had to
be eliminated. Of the remaining 63,277 genetic variations, 31,645 were previously
described in SNP databases, and 20,440 were in the intra-genic regions. This left a total of
11,192 variants. 10,735 were found were in introns, and 216 were in untranslated regions.
This left 241 variants, 60 of which were synonymous. The final 181 variants were nonsynonymous mutations, which were then actually investigated further using traditional
PCR and Sanger methods. Further extension of this vigorous elimination process yielded
ten genes with mutations, eight of which were present in nearly all tumor tissue, but whose
functions had not previously been described.
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Since this first foray into whole cancer genome sequencing, next-generation
sequencing methods have continued to be improved and have become even cheaper,
allowing more groups to utilize this methodology. The Ley et al paper, for example,
focused primarily on somatic mutations, and categorizing SNVs, insertions, and deletions
as passengers and drivers. Cancer genomes sequenced today can also be investigated for
chromosomal rearrangements, translocations, and copy number variations. In the near
future, we hope to focus on the functional characteristics in the non-coding regions of the
genome and the role somatic mutations in these regions have on cancer.
Conclusion
The ability to cheaply generate genome sequences very rapidly will undoubtedly
have many medical implications. Ultimately, the value of next generation sequencing
technologies will be in the sequencing of large numbers of samples. For example, the
ability to sequence hundreds of tumor samples will provide important information toward
understanding the microscale evolution that leads to tumor development and will be used
to design treatment protocols in the future. Furthermore, sequencing technology is rapidly
evolving and will soon allow for large scale sequencing projects to study thousands of
human genomes. Currently, having a personal genome project may be of minimal medical
value; however, once many genomes are available, we will have a very powerful tool for
uncovering the associations between the genotype and the cancer.
Figure Legends
Figure 1a. Emulsion PCR – Template DNA and beads are mixed and then put into an
emulsion mixture consisting of an oil phase and an aqueous phase of PCR reagents. These
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beads have primers complementary to the ends of the template strands coupled to them,
allowing the PCR reaction to extend these primers and cover the bead in copies of the
template DNA. Template DNA is diluted to maximize the number of emulsions having
exactly one template strand and one bead. Proceed with PCR temperature cycling.
Sequencing is performed on beads with only clones of a single template DNA, as beads
with no DNA and beads with more than one template DNA do not provide usable data.
These beads can then be fixed onto an array for sequencing and imaging.
Figure 1b. Solid Phase PCR – Very similar to ePCR, but without beads. Template DNA
is diluted and then added to a slide with primers complementary to end regions of the
template DNA coupled to the slide, which allows hybridization and priming. Through a
series of PCR temperature cycling, a slide is covered in clonal patches of DNA to be
sequenced.
Figure 1c.

Rolling Circle Amplification – A piece of linear DNA is circularized

enzymatically.

Once circularized, RCA is performed with a polymerase that has

displacement activity. This results in a ball of clonal DNA, effectively amplifying the
DNA but without the need for emulsions or beads. These balls of DNA are then coupled
to an array and sequenced.

Figure 2. Mate-Paired Libraries – Mate-paired libraries can provide alignment information
that is very valuable, especially when trying to sequence large redundant regions with short
reads. The most ideal way to sequence a large redundant region is to simply get a single
contiguous read of the entire region, however that may not be technologically possible,
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which is why this mate-paired strategy is key. Because the mate-paired reads come from
two different regions, a set distance apart, it is possible, even with short reads, that one half
of the mate-pair will be in a uniquely identifiable region, and even though the other will be
in the redundant, difficult to map region, that read will still provide useful alignment data.
Figure 3. Sequencing By Synthesis with Fluorophores – A primer is hybridized onto the
template DNA onto a universal region to allow extension by a polymerase. A single
nucleotide will incorporate due to a blocking group on the nucleotides, and the DNA will
be able to be visualized by the fluorophores attached to each nucleotide type. If there is a
saturation step, as is often the case when dealing with amplified DNA template, it would
be performed following the first extension step (not shown). A saturation step is identical
to the first step except that there is no fluorophores, though there are still blockers on the
nucleotides, and the nucleotides at usually at a very high concentration to saturate. The
fluorophores are then cleaved chemically, and then the blocking group is removed so
extension can continue another base. This cycle then repeats.
Figure 4. Sequencing By Ligation – A template strand of DNA is exposed to a population
of query primers after hybridizing an anchor primer onto a universal region. These are
degenerate for all positions except for the position of interest (2nd shown). The nucleotide
in the position of interest will determine what fluorophore is attached to this query primer.
The query primer will ligate on, allowing imaging to decode the base at the position of
interest. This query primer is then cleaved, either enzymatically or chemically, releasing
the fluorophores and exposing a new ligation site. Ligation is repeated to obtain further
positions.
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Figure 5 – Processing SNVs and filtering into somatic mutations – Comparison between
germline and tumor genomes provide somatic mutations, whereas comparison between
germline and reference genomes can offer information on inherited factors that may have
been involved in cancer risk. SNVs that are in non-genic regions, introns, etc. are filtered
out, since they either have no effect or don’t alter protein function. Validation must follow
a highly processed and shortened list of SNVs.
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Abstract
Background
Sequencing-by-ligation (SBL) is one of several next-generation sequencing
methods that has been developed for massive sequencing of DNA immobilized on arrayed
beads (or other clonal amplicons). SBL has the advantage of being easy to implement and
accessible to all because it can be performed with off-the-shelf reagents. However, SBL
has the limitation of very short read lengths.
Results
To overcome the read length limitation, research groups have developed complex
library preparation processes, which can be time-consuming, difficult, and result in low
complexity libraries. Herein we describe a variation on traditional SBL protocols that
extends the number of sequential bases that can be sequenced by using Endonuclease V to
nick a query primer, thus leaving a ligatable end extended into the unknown sequence for
further SBL cycles. To demonstrate the protocol, we constructed a known DNA sequence
and utilized our SBL variation, cyclic SBL (cSBL), to resequence this region. Using our
method, we were able to read thirteen contiguous bases in the 3' - 5' direction.
Conclusions
Combining this read length with sequencing in the 5' - 3' direction would allow a
read length of over twenty bases on a single tag. Implementing mate-paired tags and this
SBL variation could enable > 95% coverage of the genome.
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Background
Following the completion of the human genome project it is anticipated that
genome sequencing of an individual will be an aspect of routine treatment for a number of
diseases and illnesses, truly ushering in the era of personalized medicine. However, the
reality of implementing genome sequencing as a medical tool depends on the cost of
sequencing technology [1]. The price tag on the human genome project was $2.7 billion,
requiring the labor of hundreds of scientists, and a decade's worth of time [2]. By contrast,
sequencing and analyzing a human genome can now be performed for under $50,000 in
about four months' time with the labor of a few individuals [3-5]. This advance was made
possible by progressing from traditional Sanger sequencing methods to so-called "nextgeneration" methods that focused on miniaturization of the sequencing reactions, massive
parallelization of data acquisition, and computational analysis. This not only resulted in
increased sequencing speeds, but also significantly reduced the cost of genome sequencing
[6]. However, in order to expand the use of genomic analysis to the clinic, price, quality,
and speed must all be advanced further [7-14].
Sanger sequencing remains the gold standard today for accurate DNA sequencing.
Sanger sequencing can reach read lengths of up to roughly 1,000 base pairs, dwarfing most
current next-generation methods that average fewer than 100 base pairs [15]. What nextgeneration methods accomplish is massive parallelization, resulting in throughputs that are
orders of magnitude greater than Sanger sequencing. However, the throughput gains come
at a cost of a reduced read length [1,16,17]. Therefore, Sanger sequencing will remain an
essential laboratory tool for years to come; although, for the purposes of large sequencing
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projects (i.e. whole genome sequencing, exome sequencing, RNAseq, ChipSeq, etc.), nextgeneration methods are the new standard [18].
There are multiple sequencing methods that are utilized in next-generation
methods. The two most common can be broadly categorized as Sequencing By Synthesis
(SBS) [19-21] and Sequencing By Ligation (SBL) [22,23]. SBS is a method of sequencing
which utilizes a DNA Polymerase enzyme to incorporate a single fluorescently labeled
nucleotide that contains a reversible terminator. This allows a period of data acquisition
before removal of the fluorophore, reversal of the terminator, and continuation of
sequencing [24]. Additionally, there are single molecule and real-time SBS approaches
[25,26], which, as their names imply, are performed without template amplification and
sequenced in real-time using some indicator of nucleotide incorporation. In the present
work, we have focused on increasing the read length of SBL.
SBL is a straightforward enzymatic method of sequencing DNA. SBL uses known,
universal sequences that flank an unknown genomic tag as anchor primer sites [22]. An
anchor primer is hybridized to one of these known regions, and a ligatable end (3' or 5'
depending on the direction of desired sequencing) is available. An oligo, called a query
primer, is then ligated to the end of the anchor primer. The query primer is a mix of oligos
that are degenerate for all positions except a single position that is being sequenced, which
allows the sequencing of a single position based on the design of the query primer. After
sequencing a single position, the query primer and anchor primer are stripped from the
DNA template, effectively resetting the sequencing. The process begins again, sequencing
a different position by using a different query primer, and repeating until the entire
sequence of the tag has been determined [23]. Increased read length can be accomplished
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either by increasing the distance SBL can be performed in a single direction, or by
incorporating additional universal regions for more anchor primer sites [5,22].
Currently, the number of sequential bases that SBL-based approaches can sequence
is limited by loss of specificity of base pair hybridization at any distance away from the
site of ligation. Errors in the first six base pairs adjacent to the site of ligation are rare due
to the destabilizing effect of mismatches. However, at a distance of about seven base pairs,
the specificity of the SBL reaction is reduced (Figure 1). Therefore it is not possible to
simply use longer and longer query primers in order to increase SBL read lengths [27].

Figure 1. Errors and Error Rate versus Position. Unpublished results in a traditional
SBL sequencing run. These reads are separated into two parts, A and B, and are designed
either M or P for Minus or Plus, away or towards the site of attachment on the bead. These
AM and AP reads are obtained using different hybridized primers. Error and error rates,
when not using a cyclic or digestion method, results in loss of specificity the further away
a base is from the site of ligation.
44

In this manuscript, we describe a variation on SBL that utilizes a deoxyinosine in
the query primer that can be cleaved by Endonuclease V [28] to increase the read length
through successive cycles, which we refer to as cyclic SBL or cSBL. Our approach is
conceptually similar to the ABI SOLiD method of SBL, which uses a chemical cleavage
of the query primer to get extensions of read lengths. However, in contrast, our method
utilizes an enzymatic cleavage using completely off-the-shelf reagents. Deoxyinosine is a
universal base [29] that is recognized by Endonuclease V, which cleaves between the 2nd
and 3rd phosphodiester bond 3' from the deoxyinosine site [28]. Cyclic SBL is thus
identical to standard SBL except that there is a deoxyinosine incorporated in the query
primers that is used for cleavage. Therefore, after ligation of a query primer onto an anchor
primer, one can use Endonuclease V to cleave off the end of the query primer. This
cleavage results in a ligatable end with a portion of the query primer is still ligated to the
anchor primer, effectively lengthening the anchor primer for an SBL reaction to increase
the SBL read length. The cycles of ligation and Endonuclease V digestion can be repeated
to further increase the read length. We have used this approach to extend the read length
of SBL to thirteen base pairs in the 3' - 5' direction.
Results
Cyclic SBH
Three cycles of cSBL were performed, giving accurate signal for the first 13
positions of the Test Template. There was a slight increase in non-specific signal with each
cycle, but the third cycle still had clearly correct signal with an acceptable signal to noise
ratio (Figure 2).
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Figure 2. Fluorescent Intensity plotted versus position for each channel, for the Test
Template sequence. Sequenced area is underlined. 5' TCT ATG GGC AGT CGG TGA
TANGCG CTT GCA AGA GAA TGA GGA AAA CGA AGA 3'.
We were unable to sequence the 14th position and beyond using the cSBL strategy.
In order to determine the possible cause of this, we performed a series of tests to explore
whether the template DNA had been digested by the Endonuclease V treatment, since this
seemed the most likely problem. After the beads had undergone cSBL and stripping of the
sequencing strand of DNA, we hybridized a fluorescent probe to the 3' end of the DNA
loaded onto the beads and confirmed that the Test Template was still present on the bead.
We also ruled out the issue of secondary structure causing the 3' end of our Test
Template to become inaccessible. We performed folding calculations using IDTDNA's
Oligo Analyzer software (29) when constructing our Test Template specifically in order to
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avoid secondary-structure problems. Calculations for melting temperatures (TM) of
secondary structures were performed assuming 50 mM Na+ and 10 mM Mg++. This
simulated the highest folding TM at 31.5 degrees, and the fold as modeled by the software
was not located near the 14th base pair.
We additionally performed ligation at 50°C using Taq DNA Ligase (NEB), which
has a higher optimal temperature, but could not obtain the 14th position or further. We have
been unsuccessful in identifying a definitive reason for the observed sequencing limit of
13 continuous bases. However, based on the results from Figure 2, our cSBL strategy does
consistently provide at least thirteen base-pair reads in the 3' - 5' direction, and can easily
reach twenty-three bases with the addition of a flanking anchor primer site and 5' - 3'
sequencing of 10 bases.
Read Length Versus Genome Coverage
To demonstrate the feasibility of a cSBL approach to genome sequencing and
calculate gains in using cSBL over traditional SBL methods, we utilized the SawTooth
resequencing code developed at the University of New Mexico (M. Murphy et al., to be
submitted, 2011). Human genome coverage was simulated using mate-paired data ranging
from twenty-six bases to (limit of traditional SBL) to forty bases (theoretical gain from
cSBL implementation).

A set of simulated mate-paired tags, each separated by a range of 300-700 bases,
was created, ranging in size from 13 paired tags to 20 paired tags. A sufficient number of
tags were computationally generated to simulate 10 × coverage. The tags were all generated
from chromosome 1, mapped back to the entire genome, and calculations of chromosome
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1 coverage were performed. Mapping tags back to the whole genome, instead of just
chromosome 1, provided a more realistic comparison to how human genome sequencing
is typically performed [30,31]. Tags that mapped to multiple locations, whether in the
entire human genome or chromosome 1, were discarded. A tag that maps uniquely or maps
back to the reference genome in a single location provides useful data. If a tag maps
uniquely to the reference sequence, the loci where it maps are said to be covered by that
tag. For a given locus, the number of all such unique mappings when all tags are considered
is called the depth of coverage for that locus. SAWTooth uses a general hash index, perhaps
the fastest data retrieval structure. Although there are some limitations to general hash
indexes, the nature of genomic data and the specialized task of mapping paired end reads
to a reference genome, allows the use of hash indexes that circumvent these limitations.
The SawTooth mapping analysis yielded the results summarized in Figures 3, 4, 5.
Figure 3 shows raw coverage of chromosome 1 as a function of tag length. Increasing tag
lengths from thirteen to twenty, or twenty-six to forty total bases while mate-paired, results
in an increased coverage of chromosome 1 from 96% to 97.5%. Gains of coverage are
significant when the read lengths are small, but suffer from diminishing returns as read
length increases. Also, as expected, depth of coverage increases with tag length (Figure 4).
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Figure 3. Percent of sequenced regions on chromosome 1 covered by at least one
unique mapping, as a function of tag length.

Figure 4. Depth of unique coverage of sequenced regions on chromosome 1 at various tag
lengths.
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Figure 5. Simulated percentage of reads and the number of perfect matches as a
function of tag length.
Next, we performed an analysis of how many times each tag mapped to the genome.
One of the more significant benefits gained by increasing tag length from 13 to 20 bases is
that far fewer tags must be discarded because they do not map uniquely (see Figure 5). At
a tag length of 13 bases, only 57.2% of the tags are used, compared to 85.6% at a tag length
of 20, thus effectively increasing throughput.
Discussion
The cSBL protocol described here is a variation on traditional SBL that can increase
the read lengths by increasing the number of contiguous bases sequenced. Implementation
of the cSBL approach could potentially increase reads to twenty-three base pairs, or fortysix total base pairs with a mate-paired constructed library. In this manuscript, we performed
the sequencing on a test DNA template rather than a genome library. however, we expect
that any biases or mismatches in our cSBL will be exactly the same as general SBL. These
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issues include increased mismatches in specific positions of the query primer [32], or
general drops in efficiency when dealing with A or T rich regions of the genome [27].
Additionally, our experiments were performed on beads suspended in solution rather than
on beads immobilized on a surface. Therefore, to implement our sequencing strategy in a
next generation sequencing platform, the methods would need to be optimized on
immobilized beads.
Our cSBL strategy is not truly bi-directional. This is because Endonuclease V cuts
in the 3' direction relative to the deoxyinosine position. Therefore, using Endonuclease V
for cSBL in the 5' to 3' direction would result in the deoxyinosine remaining in the extended
anchor primer. This would limit the number of cSBL cycles in the 5' to 3' direction to two,
as attempts to go further will recognize the first incorporated deoxyinosine and limit the
extended reads in the 5' to 3' direction.
Conclusions
In summary, we have demonstrated that next-generation sequencing approaches
applying the cSBL variation will be able to produce longer read lengths relative to standard
SBL. Additionally, cSBL is compatible with and further increases the sequence gains from
methods that incorporate additional anchor primer sites. Also, cSBL can complement
traditional SBS approaches as cSBL can sequence in the 3' to 5' direction. This variation
of traditional SBL approaches has useful applications in many next-generation sequencing
methods that are in active use today.
Methods
We have applied cSBL to sequence a known test DNA fragment (Test Template,
see Table 1) immobilized on 1.0 um beads (MyOne Beads, Invitrogen) in solution. All
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DNA primers used were synthesized by Integrated DNA Technologies. The Test Template
was constructed not to have significant secondary structure. The 5' end of the Test Template
is modified with a dual biotin on the 5' end to couple to streptavidin-coated beads. The
anchor primers (Anchor Primer, see Table 1) were designed to hybridize onto the 5' end of
the Test Template, and provide a free 5' phosphate to ligate the query primers (Extension
Primers, see Table 1). Multiple anchor primers that were identical except that each
progressive primer was shorter by one nucleotide were used. The multiple anchor primers
allowed multiple positions to be sequenced with the same set of query. In addition to the
query primers, we used a Saturation Primer. The purpose of this was to fully saturate all
available ligatable sites, therefore combating drops in signal efficiency and phasing in
further cycles. In addition, a standard query primer that did not contain a deoxyinosine was
used to sequence the 5th and 10th positions. The 10th position was obtained following a
single cycle of cSBL.
Template
and
Primers
Test Template

Anchor

5’ (Dual Biotin) TCT ATG GGC
GAA TGA GGA AAA CGA AGA 3’
5’ (Phosphate) A TCA CCG ACT
5’ (Phosphate)
TCA CCG ACT
5’ (Phosphate)
CA CCG ACT
5’ (Phosphate)
A CCG ACT

Anchor Primer
-1 Anchor Primer
-2 Anchor Primer
-3 Anchor Primer

Extension Sequence
Primers
ExSeq4 – A
ExSeq4 – T
ExSeq4 – C
ExSeq4 – G
Saturation Primer

DNA Sequence

Query

AGT CGG TGA TAN GCG CTT GCA AGA
GCC
GCC
GCC
GCC

CAT
CAT
CAT
CAT

AGA
AGA
AGA
AGA

3’
3’
3’
3’

DNA Sequence
5’
5’
5’
5’
5’

Cy3 - NNINNANNN 3’
TYE 665 (Cy5 Analog)- NNINNTNNN 3’
6-FAM (FITC Analog)- NNINNCNNN 3’
TEX 615 (Texas Red Analog)- NNINNGNNN 3’
NNINNNNNN 3’

Table 1. Sequences of the Test Template, various Anchor Primers, and Query
Primers.

52

Binding DNA to Beads
The dual-biotin on the test template was bound to the streptavidin-coated beads
(MyOne Beads, Invitrogen, Carlsbad, CA). 30 uL of beads were washed three times in
Bind and Wash Buffer (10 mM Tris-HCl, 1 mM EDTA, 2.0 M NaCL) and collected using
a magnetic particle collector. The beads were then resuspended in 120 uL of BW Buffer
and 1.2 uL of 1 mM Test Template sequence (10 uM final concentration) was added
incubated at room temperature in a rotisserie for forty-five minutes. Finally, the beads were
washed times and resuspended in 60 ul of Wash 1E (10 mM Tris, 50 mM KCl, 2 mM
EDTA, and .01% Triton X-100).
Hybridize Anchor Primer onto Template DNA
The beads were washed in Wash 1E (10 mM Tris, 50 mM KCl, 2 mM EDTA, and
.01% Triton X-100), then washed once in a 1 × SSPE (150 mM NaCl, 10 mM NaH2PO4,
and 1 mM EDTA pH 7.4). The beads were then resuspended in 150 uL 1 × SSPE with 2
uL of 1 mM anchor primer (13 uM final concentration). The solution was incubated at
50°C for 15 minutes and then cooled to room temperature for ten minutes. Lastly, the beads
were washed in Wash 1E three times and immediately used in the Query Primer Ligation.
Query Primer Ligation
The beads were collected in resuspended in the ligation buffer (66 mM Tris-HCL,
10 mM MgCl2, 1 mM dithiothreitol, 1 mM ATP, 7.5% Polyethylene glycol [PEG6000]),
with a query primer concentration of 3 uM each, and T4 DNA Ligase (2 U/ml, NEB). The
ligation reaction was incubated at 30°C for 45 minutes on a rotisserie. Following the
reaction the beads were washed three times in Wash 1E and resuspended in Wash 1E. The
fluorescent signal was verified using a fluorescent microscope.
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Microscope Fluorescent Calibration
The exposure and gain for each fluorescent filter was adjusted with all positions
present for each cycle. Camera settings were optimized each cycle of cSBL as signal
dropped from one cycle to the next. The individual populations of beads were examined
separately with the same settings, and then scored using NIS-Elements Basic Research
imaging software (Nikon Instruments Inc, Melville, NY) (Figure 6).

Figure 6. An overlay of three channels of fluorescence. In practice, there are four
fluorescent channels, one corresponding to each base. Only three channels and the
corresponding overlay are shown here for clarity. NIS-Elements Basic Research 3.0 (Nikon
Instruments Inc, Melville, N.Y) software was used to generate this image and analyze the
data. Pixel values are taken from beads in each channel to ascertain sequencing accuracy.
The pixel values of brightness in each channel are used as a gauge of nucleotide identity.
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The pixel values of the brightest channel for a given bead and the values of other channels,
provide the signal to noise ratio for comparison.
Pixel Intensity Evaluation as a Measure of Sequencing Accuracy
NIS-Elements Basic Research 3.0 (Nikon Instruments Inc, Melville, NY) was used
to determine the pixel intensities in the Cy3, Cy5, FITC, and TxRed channels. Individual
channel intensity values ranged from 1-16,383. One-hundred pixels were averaged in each
channel and compared. This gave a metric for estimating sequencing accuracy, as the
correct signal was known for each position.
Saturation Ligation
A saturation step was performed to fully saturate all Anchor Primers sites not
extended during the Query Primer ligation cycle. The ligation was performed in a 1 × T4
DNA Ligase Buffer, with a Saturation Primer concentration of 10 uM and T4 DNA Ligase
(2 U/mL), at 30°C for forty-five minutes on a rotisserie.
Endonuclease V Digestion
The beads were washed three times and resuspended in 1 × NEB4 (50 mM
Potassium Acetate, 20 mM Tris-Acetate, 10 mM Magnesium Acetate, 1 mM
Dithiothreitol) with 100 ug/mL BSA and Endonuclease V at a 2 U/mL concentration. The
endonuclease V digestion was incubated at 37 degrees on a rotisserie for ten minutes.
Removal of the fluorescence was confirmed visually using a fluorescent microscope.
Specific digestion and negligible non-specific Endonuclease V digestion was confirmed by
an overnight incubation with Endonuclease V with test-template bound beads. The
overnight digestion resulted in no detectable non-specific endonuclease activity when
gauged by hybridizing a probe to the distal region of the Test Template.
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Endonuclease V Deactivation
Following the Endonuclease V digestion, the beads were extensively washed to
remove all Endonuclease V. Enzyme carry forward could cause phasing problems,
therefore, a guanidine wash was also performed to inactivate residual enzyme. The bead
solution was washed in a 3 M Guanidine solution at room temperature. Following the
guanidine wash, the beads were washed three time and resuspended in Wash 1E.
Cyclic Ligation
After Endonuclease V deactivation, the template DNA has been sequenced in one
position, but now the anchor primer is effectively lengthened. In traditional SBL, the
sequencing strand would be stripped to repeat the sequencing process for a different
position. With cSBL, the sequencing of additional bases is dependent upon the preservation
of the hybridized sequencing strand of DNA. The process therefore begins again with query
primer ligation, and is repeated until the signal to noise ratio is too low to effectively
continue sequencing by SBL. At that point, the entire sequencing strand can be stripped
and a different length anchor primer can be used to sequence different bases, as in
traditional SBL (Figure 7).
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Figure 7. Sequencing By Ligation with Endonuclease V Digestion. 1) Sequencing
the fourth base in the template tag, by using standard SBL with a Query Oligo that contains
a Deoxyinosine (I). 2) Endonuclease V will recognize the Deoxyinosine and cleave the
second phosphate bond towards the 3' end. The picture has white light background to make
the bead visible as all fluorescence is ablated. 3) Repeat SBL to obtain the next positions.
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ABSTRACT
Current sequencing technologies produce RNA and DNA sequence data at very
high rates. Generally, downstream analysis requires the intermediate step of mapping of
reads to a reference genome. Virtually all next-generation (post-Sanger) sequencing
platforms generate giga-base-pairs (Gbp) of data per run, often in the form of mate-paired
short–reads (1). We anticipate the daily need to sequence, and subsequently align (map)
to a reference genome, several billion mate-pair reads, or single sequence reads, in wholegenome sequencing of human samples. These reads may need to be aligned to a large
reference genome, itself comprising several Gbp, e.g. human (~3.0 Gbp), mouse (~ 2.5
Gbp), frog (~ 1.5 Gbp) or zebrafish (~ 1.5 Gbp). An efficient algorithm to perform this
mapping is essential given these large dataset sizes. Here we present the SawTooth suite
of software applications whose core functionality is the efficient mapping of short-read
sequencing data to a reference genome. SawTooth also implements several ancillary
applications for validation and statistical analysis of mapping results.

62

INTRODUCTION
Our initial motivation for developing the SawTooth mapping algorithm was to map
data generated on the Polonator polony sequencing platform (http://www.polonator.org).
This platform produces data for short-read (typically 13 or 14 bp per tag) paired-end tags
(PETs) whose approximate tag separation is known a priori, but only to within a broad
range of values. Plausible separation intervals may be several hundred or several thousand
bp. For example, a Polonator run may produce data where a single read consists of two
13bp tags with a plausible separation range between 700bp and 1200bp. Our target
computational platform was a Linux supercomputer consisting of Infiniband-coupled 8core nodes with 16GB RAM/node. (See Materials and Methods for greater detail.) The
resulting algorithm and its implementation were optimized for this core problem, mapping
13mer and 14mer PETs on the targeted computational clusters whose multi-processor
nodes provide a minimum of 16GB RAM.
For the core problem, we were able to realize speed-ups on the order of 400x over
other currently available and supported mapping software, in particular Bowtie (2),
Novoalign (http://www.novocraft.com), and SOAP2(3) . All fast contemporary mapping
algorithms, including those just mentioned, rely on indexes. These auxiliary data structures
facilitate the alignment of sample sequences to a reference genome, which we refer to as
RefG in much of the discussion below. These indexes fall generally into two broad
categories, suffix-trees and hash indexes (4). Historically, hash-based approaches were the
first class of methods to be implemented and are still being used and developed. The wellknown BLAST (5) algorithm, developed in 1990, is one example, as are SOAP (6), the
more recent Novoalign, and SawTooth, the algorithm that is the subject of this paper. We
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first discuss suffix-trees, and their performance, to motivate our reasons for using a hashbased approach.
Traditionally, the construction and use of suffix-trees imposed prohibitive memory
requirements, even when represented as suffix-arrays which contain the same information
in a more memory-efficient form (7). In recent years, however, innovations in the field of
compressed text indexes and associated search methods have rendered suffix-based
methods feasible for whole-genome indexing. (Sequence data is a special case of text and
is therefore amenable to text-based methods.) Notable examples of compressed-text
indexes are based on the Burrows-Wheeler Transform (BWT) (8) of the original text, with
subsequent compression and construction of an FM index (9) to enable in-place searching
of the compressed text. These form the basis for more recent mapping software such as
BWA (10), SOAP2 (3), and Bowtie (2).
A hash index is a well-known referencing data structure which allows key-based
data retrieval in constant, O(1), time, making it perhaps the fastest of all data retrieval
structures. It comprises three elements, a hash function, a hash table, and a data-store. The
hash table is an array of pointers to data elements held in the data-store. This array is
accessed directly via an integer offset into the array. As input the hash function takes a key,
such as a name or social security number in traditional databases, and returns the integer
offset into the hash array which contains a pointer the corresponding data. This integer
offset is often called simply the “hash” of the key. Thus, the process of locating the data
may be as fast as two memory access operations.
There are some limitations of general hash indexes that may limit their performance
or impair their usefulness (11). In the general case, keys are not ordered so sorted lists and
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range searches are not intrinsic operations on the data structures. Also, a hash function
may generate the same hash for multiple keys. These cases, known as collisions, must
somehow be resolved, requiring extra processing and access to the original keys within the
index. However, the special nature of genomic data, and our limited purpose of mapping
PETs to a reference genome, allow us to create hash indexes that are free from these
limitations. In SawTooth, the key is the sequence comprising a tag and the data to be
retrieved is an exhaustive list of loci where the tag maps in the reference genome.
Importantly, this list is ordered by locus. The hash index and retrieval process is described
in greater detail below.
The SawTooth algorithm for mapping a single mate-pair to the reference genome
proceeds in two steps:

1. Retrieve two exhaustive lists of loci in the reference genome where each of the two
paired-end tags, TAG1 and TAG2, map to the reference genome.

2. Examine all possible combinations of m TAG1 candidates and n TAG2 candidates.
Retain only those that fall within the plausible separation interval.

SawTooth can perform Step 1 in O(1) time and Step 2 in O(m+n) average time, and in
O(m*n) worst-case time. The justification for these computational complexity estimates is
provided below.
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Step 1 – Retrieving lists of loci
SawTooth accomplishes Step 1 in O(1) time by means of a pre-compiled hash index
of RefG.
This hash index consists simply of two (4-byte unsigned) integer arrays, one being
the hash array (which we refer to as OFFSET_ARRAY in the discussion below), and the
other containing the data, i.e. the ordered, exhaustive list of loci (which we refer to as
LOCI_ARRAY in the discussion below). It is built for the reference genome (as opposed
to the target data) and has these and characteristics and components.
The hash index is based on a pre-defined tag length, 12, 13, or 14 bp. The hash
function is defined as simply the binary encoding of the tag sequence. We arbitrarily code
the individual nucleotides as follows: A=00, C=01, G=10, T=11. We then create a coding
for oligonucleotides by appending the individual codes, e.g. GCAT is coded as 10010011.
As well as being an unambiguous binary coding for an oligo, this representation can be
directly treated as an integer and consequently as a direct-reference, i.e. as an offset into
an array. Tags up to length 16 can be coded into a 4-byte integer hash. Current single –
node memory constraints limit the size of the tags used to construct the hash table, i.e. the
seed-tags, to a maximum length of 14. This is a “perfect hash function” i.e. there are no
collisions and there is no need in the algorithm for collision resolution. It is invertible, i.e.,
given a hash, the original tag can be uniquely reconstructed.
The data array, LOCI_ARRAY, contains of 4-byte unsigned integers which are the
loci where every occurrence of every tag in the reference genome is listed. The hash array
OFFSET_ARRAY of 4-byte unsigned integers are the offsets into LOCI_ARRAY where
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the first locus in RefG of every possible tag occurs. If the tag occurs nowhere in RefG, then
the offset is set to 0xFFFFFFFF, which we use as a “not found marker”, NFM.
The complete list of loci where a particular tag occurs is found as follows. The tag
is translated into an integer, TAG_HASH, via the hash function, and the element
OFFSET_ARRAY[ TAG_HASH] is obtained. This is the offset into LOCI_ARRAY
where the list of loci for this tag begins. The next tag that occurs in RefG is obtained as
TAG_HASH _NEXT. This is usually simply OFFSET_ARRAY[TAG_HASH +1] but is
inspected

and

incremented

if

it

contains

a

“not

found

marker”.

Thus

OFFSET_ARRAY[TAG_HASH _NEXT] - OFFSET_ARRAY[TAG_HASH]. This is the
number of loci in the reference genome where the tag occurs. The requirements that we
have the location in memory where the list of the loci begins, and how many loci there are
for this tag, are now completely satisfied.
An example of these data structures for 3-mers appears in Table 1.
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Table 1b. Offset Array
Hash Code

Loci
Index

Tag Sequence

Array

Table 1a. Loci Array

0
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0

1
3
4
5
6
7
8
9
10
11
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13
14
15
16
17
18
19

AAC
AAG
AAT
ACA
ACC
ACG
ACT
AGA
AGC
AGG
AGT
ATA
ATC
ATG
ATT
CAA
CAC
CAG

81
105
258
266
283
303
499
513
560
585
645
693
838
900
953
969
1016
1049

. .
. .

.
.

Because the hash code is translated directly to the index of a tag in OFFSET_ARRAY there
is no need to store either the hash codes or the original tags; only the list of offsets is
required. Thus memory usage is calculated as follows: Memory to store LOCI_ARRAY ≈
4*|RefG|
Memory to

store OFFSET_ARRAY = 4*(4^SeedSize). The calculation for

LOCI_ARRAY storage is approximate because tags can begin on any base of RefG except
for those less that the hash seed size distance from either end of a contig. For the Human
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Reference Sequence b36.3 with 2,858,018,193 bases this comes to 11,432,072,772 bytes
and is independent of hash seed size.

Table 2. Memory Required for Hashing Data Structures for the
Human Reference Sequence b36.3

Number of
Possible
Hash
Distinct
Average
Memory
Total
Seed
Tags
Loci
Required By
Memory
Size (4*4^SeedSize) Per Tag OFFSET_ARRAY
Required
11
4,194,304
715
16,777,216
11,444,777,216
12

16,777,216

179

67,108,864

11,495,108,864

13

67,108,864

45

268,435,456

11,696,435,456

14

268,435,456

11

1,073,741,824

12,501,741,824

15

1,073,741,824

2.794

4,294,967,296

15,722,967,296

16

4,294,967,296

0.698

17,179,869,184

28,607,869,184

17

17,179,869,184

0.175

68,719,476,736

80,147,476,736
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Step 2 – Filtering pairs with plausible separation
A naïve approach to filtering tag-pairs with plausible separation would be to actually
examine every one of the m*n combinations. This, however, is unnecessary. SawTooth
accomplishes Step 2 in O(m+n) average time by exploiting the fact that the two lists of loci
are both ordered by locus. This ordering has two consequences.

1- When looking for the mates for particular TAG1 locus, there is no need to
examine any TAG2 loci after encountering the first TAG2 locus that exceeds the
maximum separation. Because they are ordered, all subsequent TAG2 loci in the
TAG2 locus list are greater still, and must also exceed the maximum separation.

2- Once the plausible TAG2 mates for a particular TAG1, say TAG1 locus(i), have
been found, the search for mates to the next TAG1 locus , TAG1 locus(i+1) may
begin with the first TAG2 locus hat was a mate for TAG1 locus(i). In the case where
TAG1 locus(i) had no mates, the search can begin with the last TAG2 locus
examined which was the first which exceeded the maximum separation from TAG1
locus(i) .

These two constraints allow, in the case of typical tags, for a single traversal of each
the two loci lists, with occasional re-examination of TAG2 loci, and requiring O(m+n)
comparisons. The worst case O(m*n) occurs when every TAG2 is a plausible mate for
every TAG1 as would happen in a long sequence of replicated monomers. This situation is
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easily handled by terminating the search when a maximum number of matches have been
found.

Extension of Paired-End Mapping to the Mapping of Longer Tags

The algorithm described above has been extended in SawTooth to handle tags of
arbitrary length, whether as single tags or paired-end tags of length greater than 14. The
extension based on the fact that the result of pair separation filtering is an ordered list of
loci, just as is the result of a search in the hash-index. With that in mind, the extension to
longer tags is obvious and direct. Longer single tags are simply split into sub-tags with the
same length as the seed, and treated as mate-pairs with a separation of 0 for contiguous
sub-tags, or negative separation for overlapping sub-tags. For example, using an index seed
length of 14, a longer tag of length 35 is split into 3 sub-tags beginning at positions in the
original tag of 1, 15, and 21 as in the representation below.
Tag: ACGTACGTACGTACGTACGTACGTACGTACGTAC
T01: ACGTACGTACGTAC
T15:
GTACGTACGTACGT
T21:
CGTACGTACGTAC

The lists of loci for T15 and T21 are filtered for a separation of exactly -7. The
resulting list of loci is filtered with the T01 list for a separation of exactly 0. For longer
tags yet, the process is repeatedly applied.
The list of loci for single tags produced this way are de-referenced and reported as
mapping results. For paired-end tags, the lists of loci are then submitted to the pair
separation filtering algorithm.
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Other Tools in the SawTooth Toolkit
In addition to the core functionality described above, SawTooth implements several
other tools for the processing, validation and analysis of mapping results. These include:


Building, saving and loading hash indexes based on multiple FASTA files and

multiple-section FASTA files whether genomic or transcriptomic.


Generating sample tags and tag-pairs from a reference sequence



Validating results for correctness against the reference genome



Comparison of results generated by different mapping software



Analysis of mapping results to determine depth of coverage



Translation between various formats of input and results files

MATERIALS AND METHODS
ANSI C/C++ was chosen as the core development computer language for
SawTooth for several reasons. It is available in the Microsoft Visual Studio environment,
which provides a convenient development platform and is portable to our target Linux
production architecture. Second, the language modularity and the availability of stubs for
the Message Passing Interface (MPI) specification (12) led to code that is easily extensible
with respect to its algorithmic and parallel (multi-node) capabilities. Third, C++ provides
intrinsic high level data-structures such as vectors, lists, maps, and strings, along with fast
and reliable algorithms that operate on them, through the Standard Template Library
(STL). Finally, strict adherence to the ANSI language standard ensures that that SawTooth
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will be portable across a great variety of platforms. SawTooth is currently implemented on
both Intel and PowerPC hardware architectures. It runs under the Linux, Windows, and
AIX operating systems; and has been successfully compiled with Microsoft Visual Studio,
the GNU G++ compiler, the Cygwin G++ compiler, the Intel ICC compiler, and the IBM
XLC compiler.
On-node multi-processor performance was implemented through the OpenMP
multi-threading library. Multi-node, distributed computing enhancements, primarily for
segmented hash tables, are under development using the MPI.
Performance benchmarking was performed on a 1792 node/14,336-processor-core,
172 TFlop SGI/Intel Altix ICE 8200 supercomputer (Intel Xeon 3.0 GHz, 64-bit
architecture; 8 cores/node, 16 GB RAM/node; high-speed InfiniBand and IPC networks).
Code validation was performed on a smaller version of this architecture (22 nodes).
Timings for all benchmarks reported below are based on elapsed wall-time, expressed in
seconds. All tests were performed via batch submission on dedicated nodes, with no
processes running other than the mapping software and system processes.
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RESULTS
Benchmarks for the purpose comparison of search times among SawTooth, Bowtie,
and Novoalign were performed in identical execution environments. Except for the
benchmarking with respect to number of processors each application was run
simultaneously on 8 nodes, utilizing all 8 processors (cores) on each node.

Validation Test 1: checked 2 million mappings, exact correspondence with Novo some
differences with Bowtie.
Benchmark Test 1: search times to map 10M paired-end tags of various sizes 13-20

Tag
Size
(bp)

SawTooth
(sec.)

Novoalign
(sec.)

Bowtie
(Seconds)

Speedup
Relative
to
Novoalign

Speedup
Relative to
Bowtie

14

463

152588

0

329

15

558

135556

0

243

16

519

184003

100919

355

194

17

479

153142

70849

319

148

18

448

126530

51069

282

114

19

428

103814

38754

242

90

20

409

86302

31236

211

76

Table 1. Bowtie and SawTooth search times (sec.) to map 10M paired-end tags of
various tag sizes. The SawTooth index was built with seed size 14.
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Benchmark Test 2: Search times to map 10M single tags various sizes 20-120

Single
Tag Size
(bp)
20

SawTooth Novoalign
(sec.)
(sec.)
240
45792

Bowtie
(sec.)
77

Speedup
Relative to
Novoalign
190.8

Speedup
Relative
to
Bowtie
0.32

25

250

22141

73

88.6

0.29

30

286

11861

73

41.4

0.26

35

272

7195

74

26.4

0.27

40

258

2979

76

11.5

0.30

45

269

1763

78

6.6

0.29

50

261

1763

81

6.8

0.31

60

262

1556

87

5.9

0.33

70

256

1644

93

6.4

0.36

80

262

1519

100

5.8

0.38

90

263

1907

107

7.2

0.41

100

265

1330

114

5.0

0.43

110

264

1866

121

7.1

0.46

120

268

2501

129

9.3

0.48

75

Times to Map Single Tags of Various Sizes from 20 to 120
400

50000
45000

Time to Map 10M Tags (sec.)

350

40000
300
35000
250

30000

200
150

25000

Saw Seed 14

20000

Bowtie

15000
100
10000
50

5000

0

0
20

40

60

80

Tag Size in bp

76

100

120

Novoalign

Benchmark Test 3: Search times to map 1M paired-end tags size 16 using 1-8 cores

Sawtooth Bowtie
Novo
Cores Speedup Speedup Speedup
1
1.0
1.0
1.0
2

2.0

1.9

1.8

3

2.9

2.9

2.7

4

3.9

3.7

3.5

5

4.6

4.5

4.6

6

5.1

5.2

5.4

7

5.3

5.8

6.0

8

5.5

6.4

6.6

8

Speedup

6

Sawtooth
Speedup

4

Bowtie Speedup
2
Novo Speedup

0
1 2 3 4 5 6 7 8
Number of Cores
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Benchmark Test 4: search times to map 10M paired-end tags size 16 to various sized
genomes, where maps are known to exist a priori (adding successive subsets of
chromosomes that add up 300Mbp increments to chr1)

Reference
Chromosomes Genome
in Reference
Size in
Sequence
Mbp
1 to 1
225

SawTooth
Bowtie
Novoalign
SawTooth Bowtie Novoalign Slowdown Slowdown Slowdown
(sec.)
(sec.)
(sec.)
Factor
Factor
Factor
86
5418
14731
1.0
1.0
1.0

1 to 2

463

97

11526

26861

2.1

1.1

2.1

1 to 5

1022

135

26953

55601

4.5

1.6

5.0

1 to 8

1487

190

42766

83436

6.6

2.2

7.9

1 to 12

2000

260

62652

117471

8.9

3.0
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Benchmark Test 5: search times to map 1M paired-end tags sizes 13 to 20 to the
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DISCUSSION
While much recent work is devoted to developing suffix-tree based mappers, hashbased mappers still have the potential for superior performance. SawTooth is one such
application that provides a significant speed up over current suffix-tree based mappers and
previous hash-based mappers.
In addressing the core problem for which SawTooth was developed, i.e. the exact
mapping of short (13mer to 20mer) paired end tags to a large (~3Gbp) reference sequence,
it provides speedups of 76 to several hundred over other popular mapping software
packages (Bowtie and Novoalign)
Spaced-seed indexing (14) can greatly increase the specificity of mapping longer
tags and improve performance in that area where SawTooth lags. (15)(16)(17). The seed
sequences on which the hash index is based need not be contiguous. In the simplest
implementation of a spaced-seed index the seeds are composed of every nth base in the
reference sequence, perhaps every third or fourth. A spaced-seed index based on every
fourth base and of net seed length 14 would span a region of 43 (4*13 +1) bases in the
reference sequence.
The next phase of development will be to implement SNP/SNV discovery. This
may be accomplished by one of several different methods. SawTooth is still in an early
stage of development and these directions for future development seem very promising.
We believe that the SawTooth algorithm may be improved. We further believe that the
methodology is so powerful that it may serve as the kernel of hybrid algorithms
incorporating various other methods and concepts. Possible areas of future efforts are as
follows.
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SNP discovery can be accomplished immediately by simply permuting each base
in the target tags and repeatedly applying the existing algorithm. This brute force approach
is computationally intensive; permuting each base through three alternates in paired-end
14mers requires 84 (3x28) iterations of the algorithm. However the speed of SawTooth
makes this approach feasible.
In a more promising approach, the very fast exact mapping of 14-mer pairs could
be used to provide small sets of candidate sequence alignments which may then be
analyzed by more comprehensive yet much slower homology scoring algorithms such as
Smith–Waterman which requires O(mn) time and space. This is an approach similar to that
used by the BLAST algorithm for generalized sequence alignments. This approach would
lead directly to the detection of

indels, (insertions and deletions (18) as well as

polymorphisms.

FUNDING

This work was supported by the National Institutes of Health NCE [# R21
G004350/564251], and the National Science Foundation [DGE-0549500]."

82

REFERENCES
1. Metzker,M.L. (2010) Sequencing technologies - the next generation. Nat Rev Genet, 11,
31-46, 10.1038/nrg2626.
2. Langmead,B., Trapnell,C., Pop,M. and Salzberg,S.L. (2009) Ultrafast and memoryefficient alignment of short DNA sequences to the human genome. Genome Biol,
10, R25, 10.1186/gb-2009-10-3-r25.
3. Li,R., Yu,C., Li,Y., Lam,T.-W., Yiu,S.-M., Kristiansen,K. and Wang,J. (2009) SOAP2:
an improved ultrafast tool for short read alignment. Bioinformatics, 25, 1966 -1967,
10.1093/bioinformatics/btp336.
4. Li,H. and Homer,N. (2010) A survey of sequence alignment algorithms for nextgeneration sequencing. Briefings in Bioinformatics, 11, 473 -483,
10.1093/bib/bbq015.
5. Altschul, &#32;S, Gish, &#32;W, Miller, &#32;W, Myers, &#32;E and Lipman,
&#32;D (1990) Basic Local Alignment Search Tool. Journal of Molecular Biology,
215, 403–410, 10.1006/jmbi.1990.9999.
6. Li,R., Li,Y., Kristiansen,K. and Wang,J. (2008) SOAP: short oligonucleotide alignment
program. Bioinformatics, 24, 713 -714, 10.1093/bioinformatics/btn025.
7. Navarro,G. and Mäkinen,V. (2006) Compressed full-text indexes. ACM COMPUTING
SURVEYS, 39, 2007.
8. D,B.M. and W. and Burrows M and Wheeler D (1994) A block sorting lossless data
compression algorithm Technical Report 124, Digital Equipment Corporation
Available
at:
http://www.hpl.hp.com/techreports/Compaq-DEC/SRC-RR124.html.
9. Ferragina,P. and Manzini,G. (2000) Opportunistic data structures with applications. In
Proceedings of the 41st Annual Symposium on Foundations of Computer Science.
IEEE Computer Society, Washington, DC, USA, p. 390–. Available at:
http://portal.acm.org/citation.cfm?id=795666.796543 [Accessed May 25, 2011].
10. Li H,D.R. and Li H, Durbin R (2009) Fast and accurate short read alignment with
Burrows–Wheeler
Transform.
Bioinformatics,
25,
1754–1760,
10.1093/bioinformatics/btp324.
11. Cormen,T.H., Leiserson,C.E., Rivest,R.L. and Stein,C. (2009) Introduction to
Algorithms third edition. The MIT Press.
12. Walker,D.W., Walker,D.W., Dongarra,J.J. and Dongarra,J.J. (1996) MPI: A Standard
Message Passing Interface. Supercomputer, 12, 56–68.
13. Navarro,G. and Raffinot,M. (2007) Flexible Pattern Matching in Strings: Practical OnLine Search Algorithms for Texts and Biological Sequences 1st ed. Cambridge
University Press.
14. Trapnell,C. and Salzberg,S.L. (2009) How to map billions of short reads onto genomes.
Nat Biotechnol, 27, 455-457, 10.1038/nbt0509-455.
15. Brejova,B., Brown,D.G. and Vinar,T. (2003) Vector Seeds: An Extension to Spaced
Seeds Allows Substantial Improvements in Sensitivity and Specificity. Available
at: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.4.3097.
16. Xu,J., Brown,D., Li,M. and Ma,B. (2004) Optimizing Multiple Spaced Seeds for
Homology Search. IN: PROCEEDINGS OF THE 15TH SYMPOSIUM ON

83

COMBINATORIAL PATTERN MATCHING. VOLUME 3109 OF LECTURE
NOTES IN COMPUTER SCIENCE, 2004, 47--58.
17. Choi,K.P., Zeng,F. and Zhang,L. (2004) Good spaced seeds for homology search.
Bioinformatics, 20, 1053-1059, 10.1093/bioinformatics/bth037.
18. Kondrashov AS,R.I. and Kondrashov AS, Rogozin IB (2004) Context of deletions and
insertions in human coding sequences. Hum. Mutat., 23, 177–85,
10.1002/humu.10312.
19. Cichelli,R.J. (1980) Minimal perfect hash functions made simple. Commun. ACM, 23,
17–19, 10.1145/358808.358813.

84

Chapter 5
Paired-End Library Construction
Introduction
The initial goal of the project described in this chapter, focused on sequencing the
bacteria, Actinomyces kibdesporangium, culminating in a finished de novo draft assembly.
Sequencing was performed using an IonTorrent Personal Genome Machine (PGM). The
project subsequently shifted focus to the library construction and optimizing a library
construction protocol that would allow first paired-end and then mate-paired reads to be
obtained with the IonTorrent PGM, making de novo draft assembly more accurate and
complete (1-7).
Actinomyces kibdesporangium does not have a complete reference genome
available yet, with only a single gene cluster having been sequenced thus far. The
laboratory was approached by a chemistry lab, interested in biochemical pathways the
bacteria is capable of.
Library construction is an important precursor to sequencing, not only to produce
the DNA templates to be sequenced.

Additionally, this process can dictate what

sequencing data will be gained. Sequencing By Synthesis (SBS) must proceed in the 5’ to
3’ direction due to the usage of the enzyme DNA polymerase (8-10). Therefore, even with
the most straightforward sequence library construction methods, one can only obtain
sequence data at one end of a DNA tag (11-13). The limits of most next-generation
sequencing methods that utilize SBS reach around 200 hundred bases due to the multiparallelization that occurs (9,11,14), resulting in loss of chemical efficiency for each
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individual step. Traditional Sanger sequencing, considered the “original” SBS method, has
much lower throughput and can produce reads on the order of roughly one kilobase (9,1517). Miniaturization reduces the efficiency of the biochemistry, resulting in a significant
loss of read length, however, there is an exponential increase in the number of reads that
can be sequenced, vastly increasing overall throughput (17,18).

Different library

construction methods can consider these limitations and be tailored to obtain the most
useful data possible.
Sequencing data can be either non-paired or mate-paired. A non-paired library
provides only a single read from each tag, while a mate-paired library produces tags that
are paired, but separated in the genome by a known range of distances (9,14,17). This
distance makes it possible, using computational methods, to assemble large genomes that
may have redundant regions, and offers a greater potential for resolving ambiguous
matches (19). Though mate-paired reads are always more useful in the assembly of large
genomes, there are still reasons not to use mate pairs. Most re-sequencing of human
genomes can still provide very valuable data without mate-pairs because a reference
genome can be used to determine SNPs or indels (20). Even for de novo sequencing
projects, the genome may be small enough to be assembled without using mate-pairs
(11,20,21). The amount of labor and optimization that goes into mate-paired library
construction can be deterring factors for making a mate-paired library, especially if one is
not necessary.
This project sought to optimize a library construction method that would make it
possible to obtain paired-end reads on the IonTorrent, a next-generation sequencing
machine that utilizes SBS. This would potentially allow optimization and application of a
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mate-paired sequencing approach in the future. In this chapter, we describe the procedures
used and preliminary results from this work. However, preliminary paired Ion Torrent data
suggested our current protocol is not usable for generating paired-end data, as only a
percentage of the supposedly paired reads were actually paired, making utilization of the
data problematic.
Paired-Library Assessment
The paired-end library was constructed in a small number of runs (in Methodology
below). A paired-end run actually consists of two runs, a forward run followed by a reverse
run. In all cases, the reverse run contained fewer beads, or reads, than the forward run.
This was to be expected due to lack of efficiency in various enzymatic steps to prepare the
template DNA for the run. The IonTorrent PGM has millions of wells that the machine
can track between runs. Therefore, it is simply a matter of connecting reads obtained in
the first forward run, and pair each with the read from the corresponding well in the reverse
sequencing run. The main issue was was whether every pair of reads from a single well
would actually be paired, and therefore verification of the data needed to be performed.
Initial verification of successful paired-end sequencing was performed by using a
simple perl script (M. Murphy) that checked for overlap in the two supposedly paired
sequences. A pair of runs, a forward and a reverse sequencing run, was performed on a
bacterial genome, Actinomyces kibdesporangium. Template DNA had been size-selected
via gel electrophoresis prior to ligation of adaptors, therefore confidence that the fragment
size was in the 200-250 base range was high. For our sequencing run, we used the Ion
PGM™ 200 Xpress™ Template Kit (Cat 4474280), which creates reads roughly 200 bases
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long. Therefore, we expected to obtain paired-end reads that would be overlapping. The
data is output into three files; one forward, one reverse, and one unpaired file. We only
analyzed the first two, which contained roughly 100,000 reads. We performed a simple
check for paired-end reads by taking the last twelve bases of the forward read, and then
looking for a reverse-complement match in the supposedly paired-read in the second file.
We obtained a match roughly a quarter of the time (Table 1).
Total Pairs of Reads

96,102

Pairs with Overlapping Sequence
(Paired)
Pairs with No Overlapping Sequence
(Unpaired)

21,039 (22.02%)
74,521 (77.54%)

Table 1 – Reads evaluated with perl script for overlapping sequence as an indicator of paired reads.

We then decided to follow up and check to see if there were any paired-end reads
we did not catch due to the fact that the paired-end reads were too short to overlap, although
we predicted that this would be a fairly low percentage of our reads. We used Bowtie 2
(22) and a very rough draft genome of Actinomyces kibdesporangium, that had been
assembled by collaborators with over 2 gigabases worth of IonTorrent sequencing
information from another assembler, CLC Bio. Bowtie 2 is an assembler that can match
paired-end reads to a reference and then output statistics on what percentage of the reads
were paired-end. Bowtie 2 also distinguishes between cases where the paired reads were
concordant or discordant, meaning that they were separated or overlapped, respectively.
Using the same dataset as our initial perl script check, we were able to obtain the following
results, which somewhat affirms our quick perl script results, that only a percentage of the
paired reads were truly providing paired data (Table 2).
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Unpaired Reads
(From Unpaired Pairs above)
Did Not Align to Reference

149042
90,266 (60.56%)

Aligned Once

57,389 (38.51%)

Aligned More than Once

1387 (0.93%)

Table 2 – Bowtie 2 results, using rough draft as reference and mapping paired-end reads to verify paired-end
status.

However, in this particular dataset, we also discovered that the reads themselves
were not aligning properly to our reference genome (Did Not Align to Reference). Ideally,
the reads would map only once (Aligned Once), making evaluation possible as reads that
mapped ambiguously in multiple areas (Aligned More Than Once) cannot be used
regardless. Given the read lengths, we expected a majority of the reads to map once, given
a reliable reference genome. If anything, these results gives more insight into the current
draft and sequencing methods than it does the paired-end library. However, as seen from
Table 2, 61% of the dataset was unusable because it did not even match in the reference,
meaning Bowtie 2 could not be used to actually determine the rate of paired-end reads.
Therefore, it was determined that only reads that aligned to the genome once would be
used. The percentage of paired reads to eligible reads that actually matched to the rough
draft genome was roughly 41.8% of the reads paired (Table 3).
Total Reads that Aligned Once

101,938

Paired Pairs

42,078 (41.8%)

Unpaired Pairs

58,776 (57.6%)

Table 3 – A subset of only reads that aligned exactly once according to Bowtie 2, evaluated for
overlap, indicating paired-end reads.
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The initial expectation for this paired-end library was that most of the reads present
in the reverse run would be truly paired, instead, less than half of the reads ended up being
paired. This shortfall (Table 3) is problematic because in any de novo sequencing effort,
there is no way to ascertain which reads in the reverse run are truly paired . Even with
resequencing efforts, where a reference genome would be available, information involving
structural variations or rearrangements would be lost because none of the supposedly
paired-end data is reliable.
Future work on this project will require further optimization of the paired-end
library construction method, as it will be vital in enhancing a mate-paired library
construction method.
Methodology
Paired-End Library Construction
All protocols were adapted from IonTorrent’s Demonstrated Protocol: Paired-End
Sequencing on the PGM™ System (23).
The IonTorrent is a next-generation sequencing machine from Life Technologies
(24). It utilizes an SBS method that obtains data in real-time by using pH sensors to detect
the incorporation of nucleotides. General library construction involves shearing doublestranded DNA, and then ligating adaptors onto both ends of the DNA. The DNA template
is then single-stranded and put through an emulsion PCR (ePCR) method, that will clonally
cover polystyrene beads with the DNA template. These beads are then put into wells in a
specialized chip that is covered in pH sensors. After this, SBS will proceed from the 5’ to
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3’ end, obtaining a single read from each well – resulting in millions of beads, each
providing 150-250 bases of data.
One of the biggest changes in protocol from single-end reads to paired-end reads
involves adding an Nt.BbvCI site onto the Sequencing Primer. After sequencing the
forward reads routinely, the Nt.BbvCI enzyme is added along with T7 Endonuclease.
Nt.BbvCI will nick the recognition site, while T7 Endonuclease digests all DNA that is 3’
of the nick. This results in the original template strand being digested away while the
newly synthesized sequencing strand remains. The nick is far enough 3’ to spare the 5’
side DNA, which can then prime a follow-up SBS run, but now running in the opposite
direction, creating a paired-end read.

Figure 1 – A general summary of the paired-end sequencing strategy from (23).
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Primer Construction
The primers themselves are essentially identical the default primers used however,
there is a Nt.BbvCI site incorporated in the Adaptors and the Sequencing Primer was
altered to compensate for this. Phosphorothioate bonds are used to prevent digestion. P1
adaptors will be adhered to the bead, whereas the P2 adaptors will be free end of the DNA,
that will later prime with the Paired-End Sequencing Primer.
Oligo Name

Sequence

Paired-End
Sequencing
Primer

5’ – C*C*A*T* CTC ATC CCT GCG TGT CTC CGA C – 3’

P1 Adaptor 1

5’—CCACTACGCCTCCGCTTTCCTCTCTATGGGCAGTCGGTGATCCTCAGC —3’

P1 Adaptor 2

5’— GCTGAGGATCACCGACTGCCCATAGAGAGGAAAGCGGAGGCGTAGTGG*T*T —3'

P2 Adaptor 1

5’— CCATCTCATCCCTGCGTGTCTCCGACTCAG —3'

P2 Adaptor 2

5’— CTGAGTCGGAGACACGCAGGGATGAGATGG*T*T —3'

* = Phosphorothioate bond.

Table 1- Primer construction.

DNA Template Preparation
The genomic DNA was first fragmented, and adaptor ligated. A 200 base-read
library was prepared using Ion Xpress™ Plus Fragment Library Kit (Life Technologies.
Cat - 4471269). The only alteration was ligating the above P1 and P2 adaptors instead of
the default adaptors.
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Next, this template was clonally amplified to cover polystyrene beads via an
emulsion PCR method. This was performed with a Ion Xpress™ Template 200 Kit (Cat 4471253). This was completed with no alterations to the written protocol.
Forward Sequencing
Reagents and the protocol used for forward sequencing were performed as in the
Ion Sequencing 200 Kit (Cat - 4471258). The only change to the protocol was substituting
in the Paired-End Sequencing primer, as dicussed above. Forward sequencing was
performed as usual.
Reverse Sequencing
Reagents and the protocol used for reverse sequencing were as in the Demonstrated
Protocol: Paired-End Sequencing on the PGM™ System (Part Number – MAN0006191).
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Chapter 6
De Novo Assembler Comparison
Introduction
The process of de novo genome assembly is a complicated affair. There is a lack
of true verification of published draft genomes that will inevitably see many revisions (13). There are many programs available for assembly, all of which vary in their algorithms,
efficiencies, and effectiveness for various next-generation sequencing technologies, and
the list of assemblers is still growing every day (3). The process of choosing an assembler
and optimizing is a challenge that has growing complications by the day.
De novo assembly and mapping assembly are two distinct tasks. De novo, as the
term implies, is from nothing, and refers to the assembly of a genome utterly from scratch
(1,3-6). On the other hand, mapping assembly takes next-generation sequencing data and
compares it to an available reference genome (1,7,8). The information gained from each
endeavor varies as well. De novo assembly culminates in the completion of a draft genome,
providing basic genome structure, gene synteny, and protein information (2,5,9). A
mapping assembly requires a reference genome, but can provide insight into differences
between sample genomes and the reference genome. These differences can be structural
variations, Single Nucleotide Variations and Indels, expression differences, epigenetic
factors, or copy number variations (10-14). These variations, in turn, can be potential
contributing factors of phenotypes or disease states of interest.
Preliminary data regarding the de novo assembly of Actinomyces kibdesporangium,
as described in chapter 5, prompted a need to evaluate assemblers. An issue complicating
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the generation of a de novo draft quality genome is the lack of verification. One can provide
evidence of a strong dataset, provide quality control data regarding the acquired sequence
data, but there is no method to directly verify the accuracy of a draft genome (15,16).
Often, published draft genomes undergo multiple revisions as the genome is re-sequenced
and reassembled, gaining more detailed annotations as further painstaking work is
performed to verify the genome (17,18). Therefore, one cannot simply generate a draft
genome using multiple assemblers and determine from those results which draft genome
is the most accurate. Granted, many programs include internal checks that can provide
various relevant metrics such as contig sizes and coverage, but there is no way to measure
mistakes in alignment or base calling.
This work attempts to evaluate the capabilities of three popular de novo assemblers
by assembling a well-characterized reference genome: Escherichia coli K12 MG1655. The
assemblers tested are MIRA (Mimicking Intelligent Read Assembly), CLC Genomics
Workbench, and Velvet Assembler (19,20).

In addition to testing the assemblers,

experimental data from Ion Torrent, Illumina / Solexa, and Roche 454 were obtained for
E. coli K12 MG1655. These sequencing data were put through the various packages to
create multiple de novo assemblies. These assemblies were then compared to the reference
genome using the Mauve Multiple Genome Alignment program (21), which gave data
regarding contig length, percentage of genome covered, as well as misalignments, gaps in
alignment, and incorrect base calls (22).

Using a reference genome provided an

opportunity to evaluate de novo assemblies, which would not be possible when comparing
true de novo sequencing efforts (21,23,24).

97

Results
As expected, there was no clear, undisputed best performing assembler. Choice of
assembler will depend on largely on the data on hand to be assembled. Generally speaking,
relying purely on contig length, Roche 454 data is best assembled on CLC Genomic
Workbench, Ion Torrent is best assembled on MIRA, and Illumina / Solexa data generates
the longest contigs using Velvet Assembler.
MIRA seemed to perform very poorly with Solexa reads, which are mate-paired.
However, when given longer reads, as in the case of Roche 454 and Ion Torrent data, Mira
did much better, and was best in assembling Ion Torrent data, which provided 300-500
base read lengths. This is in spite of the fact that the data is prone to homopolymer errors,
where there are multiples of the same base in a row. In general, yields lower quality reads
than Solexa, though there are typically a greater number of reads. This implies that with
MIRA, the size of read lengths, assuming adequate data quality, is an important factor for
obtaining higher quality assemblies.
Velvet Assembler, in contrast, performed very poorly with longer reads, especially
if the accuracy of the reads were lower. Roche 454 data available was of higher quality,
but shorter than Ion Torrent data. Velvet assembled 454 data poorly, but when given Ion
Torrent data, Velvet Assembler could not even complete an assembly, running out of
memory even on a machine with 16 GB of RAM, implying that the algorithms that Velvet
Assembler used created too many contigs that were very small in size, and overly taxed the
computer system. However, when given very accurate, shorter data from Solexa, Velvet
was able to create the longest contigs out of any of the datasets. It seems that the most
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important factor for Velvet Assembler is the accuracy of reads, and that the algorithms
Velvet Assembler employs for dealing with less accurate reads are ineffective.
CLC Genomics Workbench seems to fall somewhere in between the niche
specialties of Velvet Assembler and MIRA. CLC was able to generate the longest contigs
with 454 data, which are longer than Solexa reads, but shorter than the Ion Torrent reads.
CLC Bio was still able to assemble any of the data types adequately, but was outperformed
by Ion Torrent data on MIRA and Solexa data on Velvet Assembler.
Initial Mapping of Sequence Data
Prior to using Mauve to compare the de novo assemblies that the various programs
would create, a mapping was performed using the respective experimental data. The reason
for this was that there was concern that the individual E. coli K12 MG1655 strains may
have SNPs, indels, or rearrangements that may have inflated the perceived errors rates of
the assemblers. The mapping was performed using CLC Bio with the experimental data
that was also used in the de novo assemblies.
Fortunately, as predicted, the number of SNPs observed from the mapping was very
low, numbering about a dozen (Table 1). Considering the number of SNPs found from the
assembly numbered in the hundreds, it was concluded that SNPs from the individual strains
from the specific sequencing runs did not result in significant differences (Table 1).
Additionally, the variants detected in the CLC Bio mapping are most likely not all
real variants. One must consider the frequencies of the SNP detected, the coverage, and
the type of error that was detected. For example, both Ion Torrent and Roche 454
sequencing are prone to producing Indel errors. The developers of mappers, such as CLC
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Bio, are well aware of this issue, therefore, the software has options to filter out
homopolymer errors. Despite this built-in filter effect, there were still Indel errors that
were detected by CLC Bio (see Table 1) and especially Ion Torrent (see Supplementary
Table 4).
There seemed to be a correlation between the frequencies of detected mapping
variants and the presence of that same SNV or Indel in the de novo assembly and genome
comparisons performed by Mauve. In general, if a variant was detected with 100%
frequency, the SNP would be present in the Mauve assembled genome as well.

Any

detected variant with a frequency lower than roughly 90%, seemed to be the result of a
sequencing error, particularly if it was an Indel variant with Roche 454 or Ion Torrent
technology.
Therefore, given that the lists of variants detected was short, and that even in these
short lists, that most of the variants detected are probably not real variants, but rather
products of sequencing error, it is safe to assume that mutation rates for the separate E. coli
K12 MG1655 strains in the different labs had very similar genomes.

Reference Consensus Variant
Allele
Position
Position
type
Length Reference Variants variants Frequencies
19780
18829
SNV
1
A
2
A/T
59.3/40.7
19796
18845
InDel
0
2
-/C
60.7/39.3
257847
254494
InDel
0
2
-/G
59.4/40.6
257869
254516
SNV
1
A
1
C
55.6
257911
254556
InDel
2
GC
2
GC/63.6/36.4
3364777
3338479
SNV
1
T
2
T/C
59.3/40.7
3558478
3528742
InDel
1
G
1
100
3957957
3921226
SNV
1
C
1
T
100
Table 1 – Variants detected from Roche 454 mapping data to reference genome

Bases Covered and Contig n50
100

Counts
16/11
17/11
19/13
15
21/12
16/11
20
15

Coverage
27
28
32
27
33
27
20
15

One significant finding was that despite the variation in assembly performance, the
number of missed bases remained relatively constant. The best performing assemblies
were both from MIRA, missed roughly 1.6% (454) and 1.2% (Ion Torrent) of the genome,
but the worst assembly (454 on Velvet), that contained the shortest contig sizes, only
missed 3.3% of the genome. While this might not seem like a large difference in
percentage, but when assembling genomes de novo, it gets exponentially more difficult to
obtain the last repetitive regions that are impossible to identify without longer reads or
extremely long mate pairs (Figure 1).

Missed and Extra Bases in Assembly
180000
160000
140000
120000
100000
80000
60000
40000
20000
0

Total bases
missed in
reference:

Total bases
extra in
assembly:

Figure 1 – Bases covered and added when comparing the various assemblies against the reference
genome.

The number of extra bases incorrectly added to the assembly, varied across our
computed experiments, and roughly corresponded to the aggressiveness of an assembly.
For example, when comparing Solexa Single and Solexa Paired, which is the same data,
with the paired data either taken into account or not, the base calls and quality scores do
not change. What does change is that the assemblers use the paired status and separation
101

in order to improve the assembly. This improves contig size, but also results in extra bases
being added to the assembly.
Contig sizes are one of the primary statistics used as a quick, though overly
simplified indicator of an assembly’s quality (Figure 2). It is true that assemblies are
always looking for longer contigs, with the theoretically final goal of having a contig that
encapsulates the entire genome.

Contig N50:
140000
120000
100000
80000
60000
40000
20000
0

Figure 2 – Contig n50. The n50 is defined as the contig size at which half the bases in all the sequences are
shorter than. Longer is indicative of a more complete assembly.

For all computational experiments performed here, Solexa data was used as a
control. Realistically, there is no reason to utilize unpaired Solexa data for assembly
purposes because the reads are mate-paired, and that inherently provides more information
than single reads. For the purposes of our comparison, Solexa Single and Solexa Paired
datasets were used separately to check that assembly statistics improved for the paired data.
If no improvements are seen when utilizing paired data, then it can be assumed that the
assembler was run incorrectly. As noted above, MIRA was unable to make use of either
102

single or paired Solexa data, though this was most likely due to the fact MIRA was not
optimized to handle such reads without access to a supercomputer. CLC Genomics
Workbench and Velvet Assembler did much better with the paired data, increasing contig
size many times over, though Velvet was more efficient, even if both CLC Bio and Velvet
have similar Solexa Single contig sizes.
We further found the contig sizes show that CLC Bio, which seemed to be the most
versatile overall, best handled 454 datasets. Ion Torrent data looked excellent in MIRA,
whereas Velvet was unable to use it at all, and CLC created a poor assembly.
Mistakes in Assembly
SNPs found with Mauve were not actually SNPs, but reflect missed base calls
because all three sequencing platforms should have been sequencing the same genomes
(Figure 3). Counter-intuitively, the number of errors increased when trying to utilize
Solexa Paired data instead of just the Solexa Single, but this was perhaps due to trying to
create a longer assembly. Velvet seems to have very sensitive SNP detection, calling
positions of uncertain sequencing SNPs, whereas other software relies on a clear alternate
“allele variant”.
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Number of SNPs:
500
450
400
350
300
250
200
150
100
50
0

Figure 3 – Number of SNPs in each assembly, an indicator of incorrect base calls. The specific SNPs
found are available in the supplementary information.

In addition to SNPs, there may be gaps in the assembly when compared to the
reference (Figure 4). The Ion Torrent data seemed to create more gaps, but definitely a
much greater amount on CLC Bio than on Mira.

Number of Gaps in Assembly:
3000
2500
2000
1500
1000
500
0

Figure 4 – Gaps in assembly.
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Finally, we examined the number of Inter-LCB Boundaries (Locally Collinear
Blocks) (Figure 5). An LCB is a region that does not contain any rearrangements. For the
purposes of our genome comparison, which is the same genome in all cases, an inter-LCB
Boundary can be thought of as a misalignment. Mauve is normally used to compare
different genomes, and in those cases, regions of the genomes may be moved around due
to recombination.

Number of Misalignments
12
10
8
6
4
2
0

Figure 5 – Number of Inter-Linear Colocalized Blocks (LCBs), or misalignments. A LCB is a block
of correctly assembled sequence, however, to align a draft genome to a reference, it may become
necessary to break these blocks of correctly assembled sequence into smaller blocks because the
assembler has placed it in a different location than the proper spot in the reference genome.

Discussion
Assembler Comparison
Choosing the proper assembler for the data on hand is very important, and as the
CLC / Velvet comparison demonstrated, contig size cannot be the only factor that is
considered. There is no denying, however, that longer contig size is a desirable metric in
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the de novo assembly of a genome. It is interesting to observe how the different assemblers
dealt with, or failed to deal with the variantions in the data. The various next-generation
sequencing technologies each have certain quirks, which are either less or more compatible
with the different assemblers. Homopolymer mistakes by the Ion Torrent or 454, for
example, caused computational problems for Velvet Assembler, although it was able to
take advantage of Solexa’s data, despite the shorter reads.
When comparing de novo assemblers, one cannot just consider n50 contig size
alone though it is a logical statistic to begin with, since it still remains a useful metric to
gauge an assembly’s effectiveness. The mistakes that the assemblers make, are another
consideration. CLC Bio, although creating shorter contigs than Mira with Ion Torrent data,
or Velvet with Solexa data made fewer misalignments, even making none with 454 and
Ion Torrent data. Seemingly, CLC Bio is a more conservative assembler that produces less
mistakes at the cost of shorter n50 contig lengths.
As new sequencing technologies emerge, correspondingly, new software will be
developed to utilize the data. Any paradigm shifts in next-generation data will provoke a
reactionary creation of software leading to entirely different computational issues that arise
with the shape of the new data. Conversely, new sequencing technology will render
irrelevant many of the issues that current software has taken pains to address and adapt to
obsolete. This is not to say that new sequencing technologies will necessarily render every
current technology moot. Sanger Sequencing is still capable of generating longer reads,
though the method has largely fallen out of use due to low throughput, and still has potential
applications. Benchmarking and comparison of software will continue to be a necessary
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part of de novo or assembly mapping, because even if the shape of data and the algorithms
of software changes, finding compatible pairings will remain a relevant endeavor.
SNV Locations Within Assemblies
As a general trend, it seems that the SNVs, often falsely, detected by the various
assemblers clustered around certain positions, roughly finding a dozen mistakes in a range
of a hundred bases in many cases for example. There did not seem to be regions in common
between the three different datasets, though there was often overlap in regions that gave
the individual assemblers the most problem. This implies that false SNV detection arose
due to using specific genomic samples prepared by the individual laboratories.
Comparison of SNVS from 454 Mapping and Assembled Genomes
Within the 454 results, only a single SNP (Position 3957957) from the mapping
was found in the Mira and CLCBio assemblies, implying that this is a real SNP. Velvet
failed to detect the same SNP.
Comparison of SNVs from Ion Torrent Mapping and Assembled Genomes
There were many SNVs detected, though many were falsely detected due to the
technology used. Therefore, only SNPs were examined in-depth. SNPs found in the
mapping with 100% presence and consequently detected in at least the MIRA assembly
were found at (57694, 2143337, and 3957957). CLCBio failed to detect any of these SNPs
that were observed in the mapping and was corroborated by the MIRA assembly.
Comparison of SNVs from Solexa Mapping and Assembled Genomes
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There were two sets of Solexa data, due to the fact that the data was analyzed both
correctly assuming and utilizing the paired information, and incorrectly assuming and
ignoring paired data in a ‘Single’ run. There were thirteen SNPs found in the Single
mapping (257911, 547694, 547836, 1773495, 2171387, 3364777, 3421312, 3558478,
3957957, 4038792, 4169912, and 4294405). Of these, only six were found in the Paired
run (547694, 1773495, 3421312, 3957957, 4038792, and 4169912). This seems intuitive
that within a mapping context, the paired data would lead to more accurate SNV calling,
as opposed to assemblies where using paired data gave longer contigs, but resulted in more
false SNVs being called.
SNP
Position
547694

CLCBio

MIRA

Velvet

Yes

No

Yes

1773495

Yes

No

No

3421312

No

No

No

3957957

Yes

No

Yes

4038792

No

No

No

4169912

No

No

Yes

SNP at Position 547694
Interestingly, there was a SNP found in the Ion Torrent, Single, and Paired Solexa
Mappings, though not the 454 Mapping. However, using the same 454 data, all three
assemblers, CLCBio, MIRA, and Velvet, detected the same SNV at that exact location.
This implies that this detected SNP, across three different laboratory specimens, may be an
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actual SNV of the strain. The three sequencing runs were performed from the same E. coli
K12, MG1655 strain, but they were performed by different laboratories. Additionally, no
other SNP is detected in common besides this particular one.
Methodology
Data Sets
All sequencing information was obtained from sequencing runs of Escherichia coli
K12 (NC_010473), strain MG1655. The Roche 454 dataset was downloaded from CLC
Bio’s publically available dataset (http://www.clcbio.com/support/downloads/). The Illumina
Solexa

data

was

obtained

from

(http://www.illumina.com/systems/miseq/scientific_data.ilmn).

the

company

website

The Ion Torrent dataset was

obtained from the company’s main page (http://ioncommunity.lifetechnologies.com/docs/DOC2265) (See Table 2).

Sequencing Platform

Coverage

Read Structure

Roche 454

21.7

Single ~ 225 bases

Solexa

37.9

Paired 35 bases
Separated by 150-300

Ion Torrent

47.1

Single ~ 430 bases

Table 2 – Sequencing platforms and dataset coverage.

CLC Genomics Workbench
CLC Genomics Workbench is a commercial, licensed product, and as such,
required the least amount of optimization and effort to run. All sequencing data was
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imported with default options, required no additional pre- or post-processing, and were all
assembled with specialized settings that were developer-recommended. The only option
that had to be selected was the homopolymer filter when dealing with Roche 454 and Ion
Torrent data, to prevent the homopolymer miscalls from being called Indels.
Velvet Assembler
Roche 454
Data came as two files, a fasta file and a .qual file. Pre-processing was performed
with Galaxy 101 (https://main.g2.bx.psu.edu/root), to combine both files into a single fastq
file.
The command lines used to run Velvet were:
./velveth 454Galaxy53 53 –fastq –short data/454EColiGalaxy.fastq
./velvetg 454Galaxy53/ -cov_cutoff auto –exp_cov auto
–min_contig_lgth 300

The first command line created the directory 454Galaxy53 with a 53 k-mer size,
and designated the merged fastq file as input. 53 k-mer size was chosen based on running
all possible k-mer sizes from 15 to 61, and choosing the run that yielded the largest n50.
The second command performed the actual assembly, with automatically-chosen
coverage cutoffs and expected coverage. A minimum contig length of 300 was chosen to
filter out contigs too short to be useful.
Ion Torrent
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None of the Ion Torrent runs finished on Velvet due to memory limitations. No
pre-processing was necessary.
The command lines were as follows:
./velveth IonTorEColi 21 21 –short –fastq data/EColi_in.iontor.fastq
./velvetg IonTorEColi21 –cov_cutoff auto –exp_cov auto
–min_contig_lgth 200

Solexa Single
The command lines were as follows:
./velveth SolexaEColiSingle21 21 –short –fastq
data/s_1_1sequence.fastq data/s_1_2sequence.fastq

./velvetg SolexaEColiSingle21 –cut_off auto –exp_cov auto
–min_contig_lgth 100

Solexa Paired
Pre-processing was necessary to reformat the two fastq files, which contained each
half of the mate-paired reads, however Velvet Assembler assumes that the paired reads are
next to their mate pair. A perl script, bundled in with the software package was able to
shuffle the sequences (shuffleSequences_fasta.pl), but otherwise, quality scores and bases
were unaltered.
Command lines:
./velveth SolexaPaired25 25 –shortPaired –fastq data/paired_1.fastq
./velvetg SolexaPaired25 –cov_cutoff auto –exp_cov 35
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Note the –shortPaired flag in the first command line, and the use of single new fastq
file generated by the pre-processing perl script.
MIRA
Roche 454
As in the case of Velvet Assembler, the 454 data was separated into two files: an
.fna sequence file and an accompanying .qual quality file. Galaxy 101 was used to generate
a single .fastq file for MIRA.
The command line was:
mira --project=454EColiGalaxy --job=denovo,genome,accurate,454 –notraceinfo

The job flags indicate that the task was a de novo assembly of a genome. The
accurate flag was used instead of draft, and the 454 flag indicates the sequence data type.
The –notraceinfo flag indicates that the original .sff file, recommended by MIRA
developers to be included in Roche 454 assembly, was not available, and therefore would
not be used to assist in assembly.
Ion Torrent
Ion Torrent data was extracted from the original .sff data files using a third-party
script entitled sff_extract (http://bioinf.comav.upv.es/sff_extract/index.html).
The command line was:
mira --project=EColi --job=denovo,genome,accurate,iontor

Solexa Single
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Solexa files required pre-processing to be run on MIRA due to the fact that the files
were from an earlier version of the Illumina / Solexa pipeline that is no longer used. Galaxy
101 was used to convert the discontinued Solexa format into a standard Sanger .fastq
format.
The command line was:
mira --project=EColiGalaxy2 --job=denovo,genome,accurate,solexa

Solexa Paired
Running Solexa Paired data was very similar to running the single version.
The command line was:
mira --project=EColiGalaxy2 --job=denovo,genome,accurate,solexa
SOLEXA_SETTINGS -GE:tismin=150:tismax=300

The above stipulates that there are paired reads, and that the minimum and
maximum separation is 150 and 300 bases, respectively.
Mauve Genome Alignment Software
All assemblies created a .fasta file, containing a list of contigs. These contigs were
then analyzed using the Move Contigs option of Mauve. The reference file chosen was the
E. coli K12 genome, and the experimental chosen was the appropriate fasta file from each
assembly.
Mauve, broadly speaking, aligns the draft genomes created from the various
assemblers and compares it to the designated reference genome. From this, Mauve is
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capable of outputting metrics such as SNPs, rearrangements, extra or missing bases, as
indicated in previous figures in this chapter.

Figure 6 – Mauve comparison of E. coli K12 MG1655 reference genome and Ion Torrent assembly as
performed by Mira.

Figure 7 – Mauve comparison of E. coli K12 MG1655 reference genome and Solexa assembly as
performed by Velvet.
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Figure 8 – Mauve comparison of E. coli K12 MG1655 reference genome and 454 assembly as
performed by CLC Bio.
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Supplementary Information
Included below are the various data tables generated by Mauve following reference
and experimental genome comparisons.

Number of Contigs:
Number reference replicons:
Number of assembly bases:
Number of reference bases:
Number of LCBs:
Number of Blocks:
Breakpoint Distance:
DCJ Distance:
SCJ Distance:
Number of Complete Coding
Sequences:
Number of Broken Coding Sequences:
Number of SNPs:
Number of Gaps in Reference:
Number of Gaps in Assembly:
Total bases missed in reference:
Percent bases missed:
Total bases extra in assembly:
Percent bases extra:
Number of missing chromosomes:
Number of extra contigs:
Number of Shared Boundaries:
Number of Inter-LCB Boundaries:
Contig N50:
Contig N90:
Min contig length:
Max contig length:
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454CLCBio
204
1
4582488
4639675
2
106
106
106
212

454Mira
257
1
4640522
4639675
10
180
180
180
360

454Vel
765
1
4532481
4639675
16
734
734
734
1468

0
0
53
112
161
97243
2.0959 %
1308
0.0285 %
0
99
1
0
71127
23313
124
222256

0
0
41
204
186
76813
1.6556 %
24692
0.5321 %
0
82
1
4
40837
13039
193
110514

0
0
190
766
379
153855
3.3161 %
46654
1.0293 %
0
37
1
8
10773
3140
203
41423

Number of Contigs:
Number reference replicons:
Number of assembly bases:
Number of reference bases:
Number of LCBs:
Number of Blocks:
Breakpoint Distance:
DCJ Distance:
SCJ Distance:
Number of Complete Coding
Sequences:
Number of Broken Coding
Sequences:
Number of SNPs:
Number of Gaps in Reference:
Number of Gaps in Assembly:
Total bases missed in reference:
Percent bases missed:
Total bases extra in assembly:
Percent bases extra:
Number of missing
chromosomes:
Number of extra contigs:
Number of Shared Boundaries:
Number of Inter-LCB
Boundaries:
Contig N50:
Contig N90:
Min contig length:
Max contig length:

IonCLCBio
2439
1
5608622
4639675
2
287
287
287
574

IonMira
906
1
4963063
4639675
23
81
81
81
162

0

0

0
119
284
2714
139421
3.005 %
12101
0.2158 %

0
98
193
586
58793
1.2672 %
6884
0.1387 %

0
2153
2

0
837
1

0
26417
508
51
100830

10
105851
4473
66
357573
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IonVelvet
NA

Number of Contigs:
Number reference replicons:
Number of assembly bases:
Number of reference bases:
Number of LCBs:
Number of Blocks:
Breakpoint Distance:
DCJ Distance:
SCJ Distance:
Number of Complete Coding
Sequences:
Number of Broken Coding Sequences:
Number of SNPs:
Number of Gaps in Reference:
Number of Gaps in Assembly:
Total bases missed in reference:
Percent bases missed:
Total bases extra in assembly:
Percent bases extra:
Number of missing chromosomes:
Number of extra contigs:
Number of Shared Boundaries:
Number of Inter-LCB Boundaries:
Contig N50:
Contig N90:
Min contig length:
Max contig length:
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SolSinMira
168
1
4605123
4639675
8
105
105
105
210

SolPairMira
115
1
4597867
4639675
32
85
85
84
170

0
0
123
108
109
88282
1.90%
6172
0.13%
0
67
1
3
94363
23671
161
174248

0
0
82
81
86
72138
1.55%
10726
0.23%
0
44
1
17
97697
31742
185
233168

Number of Contigs:
Number reference replicons:
Number of assembly bases:
Number of reference bases:
Number of LCBs:
Number of Blocks:
Breakpoint Distance:
DCJ Distance:
SCJ Distance:
Number of Complete Coding
Sequences:
Number of Broken Coding Sequences:
Number of SNPs:
Number of Gaps in Reference:
Number of Gaps in Assembly:
Total bases missed in reference:
Percent bases missed:
Total bases extra in assembly:
Percent bases extra:
Number of missing chromosomes:
Number of extra contigs:
Number of Shared Boundaries:
Number of Inter-LCB Boundaries:
Contig N50:
Contig N90:
Min contig length:
Max contig length:

SolSinCLCBio
243
1
4591999
4639675
4
120
120
120
240

SolPairCLC
756
1
4747382
4639675
11
95
95
94
190

0
0
70
115
108
150526
3.2443 %
1162
0.0253 %
0
124
1
2
63634
17186
153
183879

0
0
151
107
105
95024
2.0481 %
3563
0.0751 %
0
667
1
4
105511
14826
107
204893
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Number of Contigs:
Number reference replicons:
Number of assembly bases:
Number of reference bases:
Number of LCBs:
Number of Blocks:
Breakpoint Distance:
DCJ Distance:
SCJ Distance:
Number of Complete Coding
Sequences:
Number of Broken Coding Sequences:
Number of SNPs:
Number of Gaps in Reference:
Number of Gaps in Assembly:
Total bases missed in reference:
Percent bases missed:
Total bases extra in assembly:
Percent bases extra:
Number of missing chromosomes:
Number of extra contigs:
Number of Shared Boundaries:
Number of Inter-LCB Boundaries:
Contig N50:
Contig N90:
Min contig length:
Max contig length:
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SolSinVel
231
1
4571703
4639675
8
127
127
127
254

SolPairVel
138
1
4578906
4639675
14
73
73
73
146

0
0
114
135
131
107034
2.3069 %
2833
0.062 %
0
107
1
4
72848
19239
121
174094

0
0
435
135
133
97615
2.1039 %
10125
0.2211 %
0
73
1
5
132727
33502
121
390878

Single Nucleotide Variation Mapping Information
Reference
Position

Consensus
Position

Variant
type

547694

542071

SNV

1

A

1

G

1773495

1762314

SNV

1

T

2

C/T

56.8/40.5

21/15

3421312

3401828

SNV

1

A

2

C/A

51.5/45.5

17/15

3957957

3930210

SNV

1

C

1

T

4038792

4009478

SNV

1

T

2

T/G

58.1/41.9

25/18

4169912
4137318 SNV
1 T
Supplementary Table 1 – Illumina Paired SNVs

2

T/G

62.8/37.2

27/16

Length

Reference

Reference Consensus Variant
Position
Position
type
Length Reference
257911
253956
InDel
2
GC
547694
537927
SNV
1
A
547836
538069
InDel
0
1773495
1754290
SNV
1
T
2171387
2148528
InDel
0
3364777
3332422
SNV
1
T
3421312
3388957
SNV
1
A
3558478
3522267
InDel
1
G
3957957
3912982
SNV
1
C
4038792
3990504
SNV
1
T
4169912
4117421
SNV
1
T
4294405
4237561
InDel
0
Supplementary Table 2 – Illumina Single SNVs

Allele
variants

Variants

Variants
2
1
1
2
1
2
1
1
1
2
2
1

Allele
variants
GC/G
G
C/T
CC
T/C
C
T
T/G
T/G
GC

Frequencies

Counts

100

207

100

Frequencies
63.0/37.0
100
93.2
53.3/46.7
86.4
63.7/36.3
50
98.9
100
57.7/42.3
64.7/35.3
90.9
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Counts
51/30
100
82
8/7
51
86/49
7
88
70
15/11
11/6
40

Coverage
81
100
88
15
59
135
14
89
70
26
17
44

Reference
Position

Consensus
Position

Variant
type

Length

Reference

Variants

Allele
variants

Frequencies

Counts

Coverage

19780

18829

SNV

1

A

2

A/T

59.3/40.7

16/11

27

19796

18845

InDel

0

-

2

-/C

60.7/39.3

17/11

28

257847

254494

InDel

0

-

2

-/G

59.4/40.6

19/13

32

257869

254516

SNV

1

A

1

C

55.6

15

27

257911

254556

InDel

2

GC

2

GC/-

63.6/36.4

21/12

33

3364777

3338479

SNV

1

T

2

T/C

59.3/40.7

16/11

27

3558478

3528742

InDel

1

G

1

-

100

20

20
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3957957
3921226
SNV
1
Supplementary Table 3 – Roche 454 SNVs

C

1

T

Reference Consensus Variant
Allele
Position
Position
type
Length Reference Variants variants
183790
183379 InDel
1 G
2 G/475972
473903 InDel
1 C
2 C/478029
475960 InDel
1 G
2 -/G
543644
541571 InDel
1 G
1 547694
545621 SNV
1 A
1 G
579799
577214 InDel
1 C
2 C/664654
661731 InDel
1 C
1 668151
665227 InDel
1 T
2 -/T
668152
665228 InDel
1 G
2 G/730122
726896 InDel
1 C
2 C/754652
751424 InDel
1 G
1 780499
777269 InDel
1 C
1 780720
777490 InDel
1 C
1 855494
852249 InDel
1 T
1 926825
923573 InDel
1 G
2 G/1052542
1049268 InDel
1 G
2 G/1086867
1083591 InDel
1 G
2 G/1286188
1282713 InDel
1 A
2 A/1286636
1283161 InDel
1 G
2 G/1323138
1319653 InDel
1 G
1 1350393
1346905 InDel
1 C
2 -/C
1405778
1402047 InDel
1 A
2 A/1538768
1534559 InDel
1 C
2 C/1588907
1584690 InDel
1 G
2 G/1770219
1765973 InDel
1 C
2 -/C
1787705
1783453 InDel
1 G
1 1974813
1970535 InDel
1 G
1 1976527
1972249 SNV
1 G
1 T
1976560
1972279 InDel
1 G
1 2143337
2138718 SNV
1 C
1 A
2210248
2205391 InDel
1 G
2 G/2378039
2373054 InDel
1 C
2 C/2469665
2464669 InDel
1 G
2 G/2475051
2470055 InDel
1 G
1 2622901
2617544 InDel
1 C
2 C/122

100

Frequencies
58.6/37.9
64.7/35.3
52.8/47.2
53.7
93.5
55.6/44.4
37.2
59.1/40.9
58.3/41.7
50.0/50.0
43.6
35.5
60
35.9
62.9/37.1
62.3/37.7
61.8/35.3
50.0/46.2
52.4/42.9
81.8
51.5/48.5
65.0/35.0
58.1/41.9
63.6/36.4
56.3/43.8
37.9
41.7
93.3
90
100
54.8/38.7
59.6/40.4
48.5/48.5
40.9
62.5/37.5

15

15

Counts Coverage
17/11
29
22/12
34
19/17
36
29
54
43
46
15/12
27
16
43
13/9
22
7/5
12
9/9
18
17
39
11
31
12
20
14
39
39/23
62
38/23
61
21/12
34
13/12
26
11/9
21
18
22
34/32
66
26/14
40
25/18
43
28/16
44
18/14
32
22
58
15
36
14
15
9
10
71
71
17/12
31
28/19
47
16/16
33
9
22
25/15
40

2674489
2687610
2752151
3151608
3263011
3373843
3390890
3439905
3445805
3476168
3498858
3597163
3645036
3857922
3957957
3994039
4016754
4073620
4083065
4093467
4526301

2669128
2682247
2745441
3144402
3255607
3366109
3383153
3430872
3436769
3467127
3489811
3588103
3634970
3846406
3945536
3981615
4004326
4060662
4070107
4080506
4507791

InDel
InDel
InDel
InDel
InDel
InDel
InDel
InDel
InDel
InDel
InDel
InDel
InDel
InDel
SNV
InDel
InDel
InDel
InDel
InDel
InDel

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

G
G
C
C
C
C
C
G
G
C
G
G
G
A
C
G
G
C
G
G
C

2
1
2
1
2
2
1
2
2
2
2
2
2
2
1
2
2
2
1
2
2

G/C/C/-/C
G/G/C/G/G/G/A/T
G/G/C/G/-/C

58.3/41.7
39
59.0/41.0
36.6
63.6/36.4
52.9/47.1
36.5
62.5/37.5
63.6/36.4
62.2/37.8
61.9/35.7
52.4/40.5
63.8/36.2
53.8/46.2
96.8
55.6/44.4
60.4/39.6
51.5/48.5
42.9
57.6/42.4
57.9/42.1

28/20
16
23/16
15
28/16
9/8
19
25/15
35/20
23/14
26/15
22/17
30/17
21/18
30
15/12
29/19
17/16
18
34/25
11/8

Supplementary Table 4 – IonTorrent SNVs. Note, many are believed to be false positives. Despite CLC
Bio’s built-in homopolymer filter setting for 454 or Ion Torrent reads, it is assumed most of these are false
positives.
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48
41
39
41
44
17
52
40
55
37
42
42
47
39
31
27
48
33
42
59
19
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Chapter 7
Conclusion
The projects undertaken have evolved significantly during the course of its
completion; however, the main aims have always involved next-generation sequencing.
Each completed aim held a tangible goal that was reached, and they all related to nextgeneration sequencing.
First, the cSBL variation involving deoxyinosine and endonuclease V was a project
to develop and improve an aspect of next-generation sequencing, specifically, the
acquisition of sequence data. This new biochemistry was successfully demonstrated, and
provides an alternative to other proprietary methods. A lesson learned from this project
was recognizing the sheer speed of the field. There are significant commercial pressures,
and subsequently, a powerful and large private sector presence. The cSBL variation, while
demonstrated to viable, could not compete with contemporary methods offered by private
companies such as Roche 454, Illumina / Solexa, or ABI Solid in terms of pure read length.
ABI Solid uses a similar methodology, employing SBL but utilizing a chemical, as opposed
to enzymatic, cleavage. Nevertheless, although this cSBL variation may not become a
mainstream technique in a field that advances as quickly as Moore’s Law for computer
processors, this particular cSBL variation was later used in a paper that came out in August
of this year (Endonuclease V-assisted accurate cleavage of oligonucleotide probes
controlled by deoxyinosine and deoxynucleoside phosphorothioate for sequencing-byligation (1)). Despite the accomplishments in developing and optimizing such an cSBL
variation, while more evolutionary than transformative, still provides a useful alternative
and may have niche practical uses in any application that involves cycles of DNA digestion.
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In a standard sequencing pipeline, after the sequences are acquired, they must be
analyzed, and our work focus shifted to this step. The amount of data being generated by
next-generation sequencing technologies were growing, especially in the context of
discovering meaningful insight into the human genome. The development of SAWTooth
(Sequence Analysis Workbench Tool) was an attempt to address this problem. The
“shape” of the data varied, depending on the platform used to obtain the sequencing
information. For example, the data could be mate-paired or singled, and there were
tendencies toward different error types in the different codes used for analysis. Software
algorithms vary, making different codes more or less useful for each type of sequencing
project. At the time, there was a potential need in the laboratory to accumulate many
Polonator reads, which were mate-paired with a sizable separation and contained short
reads. The SAWTooth code was developed to specifically take reads in this configuration,
and match them up to a reference genome as efficiently and accurately as possible. The
results were a success, as SAWTooth outperformed its more popular contemporaries at the
time, NovaAlign and Bowtie 2. Further work on the SAWTooth project to needed, because
while the demonstrated ability to map to a reference more quickly was impressive, the code
cannot yet generate SNP or Indel information for downstream biological analysis.
Currently, SAWTooth can provide only re-sequencing metrics, or reveal copy number
variations. As mentioned earlier regarding the cSBL biochemistry, the field moves
extremely fast and the shape of the data being generated for use by the code changed within
the course of a year. Nevertheless, the basic algorithms that form the basis of SAWTooth
proved highly efficient, and clearly powerful, when utilized for the specific purpose of
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mapping short, mate-paired reads. They have the potential to be adapted to analyze reads
from other technologies should this prove useful.
The last project in this work was one of meta-analysis; to compare the tools that
can be used to generate a de novo assembly. The concept of a de novo assembler
comparison is not new. Next-generation sequencing is a large and diverse field, and while
this is often a strength as a whole, it leads to numerous and diverging options when it comes
to acquisition, analysis, and assembly. Every step has multiple valid options, depending
on the scientific application, therefore, testing and assessment of which software package
should be paired with which sequencing platform for a given application becomes
extremely important. Overall, this work may serve as a useful guide for other individuals
in the field to consider when choosing assemblers for their bacterial de novo sequencing
projects. Unfortunately, the relevancy of such findings may be limited, due to the quick
speed of the field.
With that in mind, perhaps it would be prudent for next-generation sequencing work
within an academic lab to consider the large private sector presence and rapid evolution of
the technology. This is reflected in the shift in this dissertation’s projects from optimizing
biochemisties and developing software, to using available data from tested methods and
analyzing the manner in which draft genomes are created.
The work required to create a brand new method or a new biochemistry for
sequencing relies upon a series of intelligent guesses, and a process of elimination that does
not guarantee success. Completion of such a task is a manner of diligence, laboratory
competence, and time.

Time can be shortened by utilizing larger and larger staff,
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something which academic laboratories must consider in evaluating competitiveness with
the private sector. The same principles, to a lesser extent, apply to the development of
software for the field, though the private sector presence in such endeavors is smaller.
In the course of this work, the quickest path was to take already tried and tested
methodologies and generate data. The data is of great interest and can be specialized for
academic labs, looking to investigate specific organisms. This reduces competition that
may be present from trying to wholesale improve aspects of the entire field, and creates
data where publication can be more certain.
This is not to slight any of the previous accomplishments described in this
dissertation, which were hard-fought and well-earned. It is, of course, easier to utilize
useful tools, rather than attempting to improve the tools themselves. It is for this reason
that some focus in the Edwards laboratory changed from improving the tools to generating
or just obtaining data and using Genome-Wide Association studies to analyze interesting
biological questions.
However, the development of this particular cSBL biochemistry or the SAWTooth
software was still worth the effort despite the seemingly modest impact of these advances
in the field. From a personal and localized level, the efforts of creating these methods are
learning experiences that instructed those involved and gave valuable understanding.
Additionally, these advances still contribute to the growing body of knowledge that exists
in these fields. These tools exist for future scientists to use, which are a simple Pubmed
search away. Seemingly minor biochemistries or apparently niche and overly specialized
code may be useful with the right adjustments, tweaks, or the right application.
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Philosophically speaking, trying to use the best tool available may be the easiest option;
perhaps what is right, though not necessarily most expedient, is to create an optimized tool.
Genome sequencing holds great potential for altering lives in real and tangible
ways, particularly in healthcare. This has fostered a very fertile ground for private sector
presence, causing the technologies to improve and change. It is only a matter of time before
a new technology or method, whether nanopore technologies or Transmission Electron
Microscopy methods, changes the field.

This will render current “next-generation”

sequencing technologies obsolete, and industrial goals will shift from improving read
lengths to increasing electric field sensitivity. The entire game will change, and it is only
a matter of time, but the possibilities are as exciting as they are difficult to predict.
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